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PREFACE
This reportcoversthe activitiesof the ResearchTriangleInstitute's
BiomedicalApplicationsTeam programfor the periodl January1978through
31 December1978. The workwas performedin the Centerfor Technology
Applicationsunderthe technicaldirectionof Dr. J. N. Brown,Jr., Director.
Dr. Brownwas also the BiomedicalApplicationsTeam Director. Assistance
in developmentof marketingstrategywas providedby Dr. W. H. Clingmanof
WilliamH. Clingmanand Company,Inc.,a marketingand managementcon-
sultingfirm. Otherparticipantsin the programwere Dr. H. C. Beall,
Ms. D. J. Rouse,Dr. R. W. Scearce,Mr. R. L. Beadles,Mr. P. N. Kizakevich,
and Ms. M. W. Courtney.
The work reportedhereinwas supportedby the NationalAeronautics
and SpaceAdministration--ContractNo. NASL-14708.Mr. JohnSamos,Head,
TechnologyUtilizationand ApplicationsProgramsOffice,LangleyResearch
Center,was theTechnicalMonitor. Ms. SheilaAnn T. Long,TechnologyUtili-
zationEngineer--BiomedicalPrograms,was the alternateTechnicalMonitor.
The authorsgratefullyacknowledgethe contributionsof many individuals
to the successof the RTI BiomedicalApplicationsTeam program. The time
and effortcontributedby managers,engineers,and scientiststhroughout
the NationalAeronauticsand SpaceAdministrationand thatof medical
researchersand clinicianswere absolutelyessentialto programsuccess.
Industrymanagersand technicalstaffhave alwaysbeencooperativeand open
in theirparticipation.Dr. W. H. Clingmanhas continuedto increasethe
team'sunderstandingof medicalmanufacturingand marketingpracticesand
how thesepracticesimpactmedicaltechnologytransfer. The continued
contributionto the team'seffortsby Dr. F. ThomasWooten,ExecutiveAssis-
tantto the Presidentat RTI, is appreciated.Finally,Mr. JohnSamosand
Ms. SheilaLong havecontributedsignificantlyto the successof the program,
and, as technicalmonitors,theyhavealwaysbeen supportive.
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ABSTRACT
The objectiveof the ResearchTriangleInstitute(RTI)Biomedical
ApplicationsTeam is to achievewidespreadutilizationof NationalAero-
nauticsand SpaceAdministration(NASA)technologyin medicine. This
objectiveis bestapproachedby stimulatingthe introductionof new or
improvedcommerciallyavailablemedicalproductsincorporatingaerospace
technology.
A bipolardonor-recipientmodelof medicaltechnologytransferis
presentedto providea basisfor the team'smethodology.Thatmethodology
is designedto: (1) identifymedicalproblemsand NASA technologythat,
in combination,constituteopportunitiesfor successfulmedicalproducts,
(2)obtainthe earlyparticipationof industryin the transferprocess,
and (3)obtainacceptanceby themedicalcommunityof newmedicalproducts
basedon NASA technology.
One commercialtechnologytransferand six institutionaltechnology
transferswere completedin 1978. A low-costTV displaydevicedeveloped
by NASAwas transferreduringthe reportingperiodto a manufacturerof
medicalelectronics.
During1978the RTI team performedan informalstudyof the NASATech
Briefpublicationsto evaluatethe potentialof Tech Briefsas a source
of ideasfor marketableproducts. In addition,the teamconducteda
marketsurveyon the NASA BlackBag to determinethe most acceptable
configurationas well as the potentialmarket.
The team has identified17 new medicalproblemsor needsduring
the reportingperiod. Thereare currently27 activetransfercases.
For the convenienceof the reader,the namesand addressesof the
sourcesof certaincommercialproductsare includedin thisreport.
This listingdoes not constitutean endorsementby eitherthe National
Aeronauticsand SpaceAdministrationor the ResearchTriangleInstitute.
xiii
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1.0 INTRODUCTION
The preamble to the Space Act of 1958, which created the National
Aeronautics and Space Administration, says: "It is the policy of the
United States that activities in space should be devoted to peaceful
purposes for the benefit of all mankind. ''I Further, this Act of Congress
charged NASAwith providing "for the widest practical and appropriate dis-
semination of information concerning its activity and the results thereof."
The NASATechnology Utilization Program was initiated in 1962 to assist
in satisfying this Congressional obligation.
Since 1962, NASAhas been a leader and an innovator in the establish-
ment, operation, and evaluation of technology transfer programs. Through
its Tech Brief, Special Publications, Technology Survey, and Industrial
Applications Center programs, NASAhas successfully transferred the 2
results of aerospace research to the non-space-related sectors of society.
In 1966, NASA introduced a new approach to technology transfer that
involved the activities of multidisciplinary "applications teams." The
objective of these applications teams--called Biomedical Applications
Teams--was to effect the transfer of NASAtechnology to applications in
medical research and clinical medicine. The general approach of the
Biomedical Applications Teams was: (I) to identify medical problems
through direct interactions with clinicians and medical researchers,
(2) to identify potentially applicable NASAtechnology by a variety of
mechanisms, and (3) to take necessary and appropriate action to effect
actual utilization of NASAtechnology in solving technology-related
medical problems.
Since the establishment of the applications team program in 1966,
NASAhas applied the applications team concept in the transfer of tech-
nology to applications in: (I) environmental science, (2) housing
construction, (3) transportation, and (4) manufacturing processes.
At present, Biomedical Applications Teams are sponsored by NASAat
the following institutions:
Research Triangle Institute
Post Office Box 12194
Research Triangle Park, North Carolin_ 27709
1
StanfordUniversitySchoolof Medicine
701 WelchRoad
PaloAlto,California94304
Universityof Wisconsin
1500JohnsonDrive
Madison,Wisconsin 54706
This reportpresentsthe activitiesand accomplishmentsof the Biomedical
ApplicationsTeam locatedat the ResearchTriangleInstitutefor the
periodl January1978through31 December1978.
l.l BiomedicalApplicationsTeamObjectives
The primaryobjectiveof the RTI BiomedicalApplicationsTeam is to
assistNASA in achievingwidespreadutilizationof aerospacetechnologyin
the medicalfield. Widespreadutilizationimpliesthat,by the application
of NASA technologyin medicine,a significantsectorof the medicalfield
and of thoseseekingmedicalservicesrealizesomebenefit. Implicitin
this programobjectiveis thatwidespreadutilizationbe realizedin a
relativelyrapidmanner.
The successfultransferof NASAtechnologyto applicationsin the
medicalfieldvia the BiomedicalApplicationsTeam programhas been
demonstrated.2-5NASA technologyhas been successfullyappliedto ap-
plicationsboth inclinicalmedicineand in medicalresearch. These
applicationshaveresultedin advancesin medicalresearch,improved
clinicaldiagnosisand treatment,and the introductionof beneficialnew
or improvedmedicalproducts.
Whileadvancesin medicalresearchultimatelyhavewidespread
positiveimpacton the deliveryof healthcare in the UnitedStates,
medicalresearchis a slow,complex,and expensiveprocess. On the
otherhand,much can be accomplishedin a relativelyshorttimeby solving
technology-relatedproblemsin clinicalmedicine. Applicationsof
technologyin clinicalmedicineusuallyinvolvethe introductionof a
new or improvedcommerciallyavailablemedicalproduct.
Thus,the approachof the NASA BiomedicalApplicationsTeamsin
obtainingwidespreadutilizationof NASA technologyis to directits
2
effortsprimarilyto solvingproblemsthat involvethe introductionof
a new or improvedmedicalproduct. The teamstake everyopportunity
to applyNASA technologyinmedicalresearch.
This emphasison achievingwidespreadutilizationby commercializing
NASA technologyis reflectedin the activitiesand methodologyof the
BiomedicalApplicationsTeam program. The teammethodologyis built
aroundthe followingfouractivities:(1) identificationof medical
problemsand needsand potentiallyapplicableNASAtechnologiesthat
togetherconstitutea new or improvedmedicalproduct,(2) screeningof
opportunitiesto find thosethatrepresentpotentiallysuccessful
commercialproducts,(3)developmentof commercializationstrategiesthat
take intoaccountany necessaryadaptationof NASA technology,evaluations
and clinicaltrials,FDA regulations,manufacturer'smarketingsystems,and
requiredfunding,and (4) implementationand monitoringof commercialization
strategies.Thesetasksare discussedin more detailin section2.0,
TechnicalApproach.
1.2 BiomedicalApplicationsTeam
The RTI BiomedicalApplicationsTeam is a multidisciplinaryteamof
engineersand scientists.Theireducationalbackgroundsare physiology,
biophysics,engineering,biochemistry,and biomedicalengineering;their
experienceincludesbasicand appliedresearch,development,and marketing.
The individualswho participatedin the BiomedicalApplicationsTeam program
duringthe reportingperiodare:
Name ProfessionalBackground Responsibility
Dr. J. N. Brown,Jr. ElectricalEngineer BiomedicalApplications
Team Director
Mr. R. L. Beadles ElectricalEngineer InternalTechnicalConsultant
Dr. H. C. Beall Biophysics,Physiology SolutionSpecialist
Dr. W. H. Clingman* ChemicalEngineer MarketingConsultant
Ms. M. W. Courtney ResourceSpecialist SolutionAssistant
Mr. P. N. KizakevichBiomedicalEngineer InternalTechnicalConsultant
Ms. D. J. Rouse Biochemist,Physiology SolutionSpecialist
Dr. R. W. Scearce,Jr.BiomedicalEngineer SolutionSpecialist
*Dr. Clingmanis a marketingand managementconsultantto RTI.
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1.3 ParticipatingInstitutions
The BiomedicalApplicationsTeammay be viewedas one componentin
a technologytransfernetworkthat involvesindividualsat NASAheadquarters;
NASA fieldcenters;medicalinstitutions;manufacturingand marketing
firms;and otherindividuals,groups,and organizationsconcernedwith
medicaltechnologytransfer.
At present,medicalresearchersand cliniciansfrom27 medicalinsti-
tutionsparticipatein the RTI BiomedicalApplicationsTeam program. Medical
researchersand cliniciansparticipatein the programby: (1) identifying
medicalproblemsand needsappropriatefor investigationby the Biomedical
ApplicationsTeam,(2) servingas a knowledgebase on medicalproblemsand
needs,markets,and potentialapplicationsof NASAtechnology,and
(3) receivingNASA technologyto be appliedin theirmedicalresearch
programsor to be evaluatedwithintheirclinicalpractice. Figurel
presentsthe geographicalocationsof participatingmedicalinstitutions
and NASA fieldcenters. Participatinginstitutionsare listedin tableI.
1.4 Conference Attendance
Biomedical ApplicationsTeam members attend and participatein
conferencesand workshops in order to be familiar with the state of
the art of medical technologyand to discuss new product opportunities
with medical industry representatives. Conferenceattendance,pre-
sentations,and publicationsare listed in Appendix C.
1.5 Report SunTnar_
The BiomedicalApplicationsTeam's technicalapproach to technology
transfer in medicine is describedin section 2.0. Emphasis on commerciali-
zation of NASA technology is evident in the overall structureof the team's
methodology. That is, the team's activities are segmented into four major
phases leading logicallyfrom the identificationof opportunitiesfor
commercializationto the implementationand monitoring of commercialization
strategy. Within each of these four phases, program flexibilityallows
for technology transfer activitiesrelated to medical research and leading
to institutionaltechnologytransfer.
4
LEGEND
~ -RTI
*-NASA FIELD CENTER
• - PARTICIPATING INSTITUTIONS
SCALE OF MILES
400 600 800
I I !
'-.
o 200
"........ '
o ,..-... .......
0'/ r"-"-"-"-"-"-"-"r"-"-"-". ,I . .
i \ I
-j' ) !
'. r'-'-'-'-'\. .
. .~._._._.~
I , ,
'-'-.! " ."- -L ~._._._._.
i '-'''-'_.-i .
. , !! ; L·T·__ ·_·.L·..,(. .
. I ; ~.-.- .-.-'\, ; !! /e·':. .-.-
\.; 'I ._ ..-J. -.,' "iI;,;fJl".
" -'-'- i- . \ ./".-,/ ~* \. '-'j '-'-'-'~~'...,'-'-'-'-~'-'-'-'"1 . ._*....l~.-._.-.
, I I i .-.,.. . .- ".
. ., . . \ "! I ~ '.\
'i ! i 0
'. ," ! Q
.J \........ . ._. .-' .-'-'
....... J.~"
'- ....,
Figure 1. Biomedical Technology Transfer Network
TABLEI. PARTICIPATINGMEDICALINSTITUTIONS
BowmanGray School of Medicine, Wake Forest University, Winston-Salem, NC
Carnegie-Mellon Institute of Research, Pittsburgh, PA
Dorothea Dix Hospital, Raleigh, NC
Duke University Medical Center(including VA Hospital), Durham, NC
Eye Research Institute of Retina Foundation, Boston, MA
Guilford County Communications Center for the Deaf, Greensboro, NC
Jefferson Medical College, Philadelpha, PA
Johns Hopkins University Medical School, Baltimore, MD
Louisiana State University School of Dentistry, Baton Rouge, LA
Medical College of Virginia, Richmond, VA
Medical University of South Carolina, Charleston, SC
National Cancer Institute, Bethesda, MD
National Heart, Lung, and Blood Institute, Bethesda, MD
National Institute of Dental Research, Bethesda, MD
National Institute of Neurological, Communicative Disease and Stroke,
Bethesda, MD
National Institute on Aging, Bethesda, MD
Rochester General Hospital, Rochester, NY
The Children's Hospital Medical Center, Boston, MA
The University of Alabama Department of Rehabilitation, Birmingham, AL
Tulane University School of Medicine, New Orleans, LA
University of Miami School of Medicine (including VA Hospital) Miami, FL
University of Mississippi Medical Center, Jackson, MS
University of North CarolinaSchool of Medicine, Chapel Hill, NC
University of North Carolina Dental School and Research Center, Chapel
Hill, NC
Veterans Administration Hospital, Atlanta, GA
Veterans Administration Hospital, Oteen, NC
Woodrow Wilson Rehabilitation Center, Fishersville, VA
Technologytransfersbroughtto fruitionduringthe reporting
periodare documentedin sections3.1 and 4.0. One commercialtechnology
transferand six institutionaltechnologytransfersare discussed. This
documentationdescribesthe technologytransferred,the situational
contextto whichthe technologywas transferred, and the role of the
BiomedicalApplicationsTeam as a transferagent.
The team'sproblemsolvingand transferactivitiesin twenty-six
activetransfercasesare summarizedin section5.0. Projectsinactivated
duringthereportingperiodare discussedin section6.0. Two special
projectsincludedin the reportare The NASA BlackBag:An Analysisof
the CommercializationPotentialin section3.2 and The Tech BriefStudy
in section7.0. Problemstatementsdescribingmedicalproblemsand needs
identifiedby the team duringthe reportingperiodare presentedin
AppendixB.
Section8.0 is a statementof conclusionsand recommendations.
Emphasisin this statementis on what has been learnedconcerningmedical
technologytransferand how theselessonsmay be appliedin increasing
the productivityof the NASA BiomedicalApplicationsTeam program.
1.6 Definitionof Terms
BiomedicalApplicationsTeam -- A multidisciplinarygroupof engineers
and scientistsengagedin assistingNASA in achievingwidespreadutili-
zationof aerospacetechnologyin themedicalfield.
Commercialopportunity-- The combinationof a significantmedical
need or problemand appropriate,relevantNASAtechnologythatconstitutes
the basisfor a potentiallysuccessfulnew or improvedcommercialmedical
product.
Commercialtechnologytransfer-- The successfuldevelopmentand
marketingof a new or improvedmedicalproductthat incorporatesNASA
technology.
Gomputerinformationsearch-- A computerizedsearchof NASA's
aerospaceinformationbankat one of six IndustrialApplicationsCenters
(IAC's). This informationbankconsistsof more than l milliondocuments
thathave been indexedand abstractedin the Scientificand Technical
AerospaceReports(STAR's)and the InternationalAerospaceAbstracts(IAA's).
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Donor-- Organizationor individualthatoriginallydeveloped
technologythat is transferred.Withinthe contextof the Biomedical
ApplicationsTeam,NASA is the donor.
Institutionaltechnologytransfer-- The applicationof NASA
technologyto solvea significantmedicalproblemthat doesnot result
in a new or improvedmedicalproduct.
Medicalproblem(orneed)-- A specificand definabletechnology-
relatedmedicalproblemor need thatcannotbe satisfiedby commercially
availableequipmentor by the informationavailableto the problem
originatorthroughroutineinformationchannels.
Participatinginstitution-- A medicallyorientededucational
institution,hospital,medicalcenter,or governmentagencythatworks
with the BiomedicalApplicationsTeam in identifyingmedicalproblems
and needsand in evaluatingNASAtechnologythatrepresentssolutionsto
thoseproblemsand needs.
Potentialtransfer-- The identificationof technologythat has the
possibilityof solvinga particularmedicalproblemor meetsa needand
the identificationof strategyfor achievingcommercializationr
implementation.
Problemoriginator- A clinicianor medicalresearcheractively
involvedin reachinga specificmedicalobjectiveand facedwith a
specifictechnology-relatedproblemor need.
Problemstatement-- A concisewrittendescriptionof a medical
problemor need thatcontainssufficientdetailsto allowa computer
searchto be performedand sufficientinformationto enableNASA en-
gineersand scientiststo considerpossiblesolutions.
Recipient-- The clinicalmedicalsectoror medicalresearcher
thatuses or appliesthe technologytransferred.
RTOP (Researchand TechnologyObjectivesand Plans)-- A proposal
submittedby a NASA fieldcenterto NASAheadquartersfor fundingof
researchand developmentprojectsand specificallyfor fundingto
adaptNASA technologyfor applicationin medicine.
Technology-- All of the skills,techniques,and understanding
thatconstitutea specifictechnology.Technologyincludes,but is
not limitedto,hardware.
8
Technologytransfer-- Instancesin whicha specifictechnology
movesfromone situationalcontext--theone for whichit was developed--
to another. As a result,changesare seen in eitherthe technologyor
the situationto whichit is movedor both.
Transferagentforlinker)-- The individualor organization
thatplans,stimulates,and facilitatestechnology.Withinthiscon-
text,the transferagentor linkeris the BiomedicalApplicationsTeam.
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2.0 TECHNICALAPPROACH
The objectives,operations,andmethodologyof the RTI Biomedical
ApplicationsTeam are presentedin thissection. The conceptualframe-
work formedicaltechnologytransferdescribedin section2.1 facilitates
the descriptionof and suppliesa rationalefor the BiomedicalApplications
Team methodology.
2.1 ConceptualFrameworkfor MedicalTechnologyTransfer
A conceptualframeworkformedicaltechnologytransferispresented
diagrammaticallyin figure2.6 The frameworkis basicallya bipolar
donor-recipientmodel. The roleof the donor,in this case NASA,is to
reveal,disseminate,and promotetechnology.The roleof the recipient,
the medicalcommunity,is to seek out,evaluate,and utilizetechnology.
As explainedin the introduction,the primarythrustof the Biomedical
ApplicationsTeam programis to transfertechnologyby the introduction
of new and improvedmedicalproducts. Thus,a manufacturerof those
productsis includedin figure2. Medicaltechnologytransfernormally
involvesthe identificationof a medicalproblemor needwithinthe medical
community. In response,the NationalAeronauticsand SpaceAdministration
recognizesthe relevanceof specificaerospacetechnologyand makesthat
technologyavailable.The manufacturerdesigns,develops,evaluates,
and marketsa new or improvedmedicalproductthat incorporatesaerospace
technologyand representsa solutionto the medicalproblemor need.
The purposeof the transferagent*in thisframeworkis to plan,
stimulate,and facilitatesuch technologytransfer. This is the roleof
the BiomedicalApplicationsTeam.
Researchintothe processof medicaltechnologytransferat the
SyracuseUniversityResearchCenterhas concludedthatthe donor,
recipient,and manufacturerare frequentlyat crosspurposes.7The
recipientis primarilyconcernedwith solvinga problem. The manufacturer
by necessityis concernedwith introducinga commerciallyviableproduct.
The donorobtainssatisfactionas rewardfor involvementin the transfer
*The term "linker"is frequentlyused in thiscontext.
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Figure2. ConceptualFrameworkfor MedicalTechnologyTransfer
process. It is the task of the transferagentto bringthe donor,
recipient,and manufacturertogetherin such a way thateachviews
successfultechnologytransferas the primaryobjective.Completeness
of the transfereffortmust be a majorgoalfor all partiesinvolved.
The specificrole of the BiomedicalApplicationsTeam,the transfer
agent,dependsupon the motivation,competence,and organizationof
the donor,recipient,and manufacturer.NASA is highlymotivatedto
transferaerospacetechnologyto applicationsin non-space-relatedfields.
Further,its organizationis structuredto facilitatethe developmentof
sophisticatedand advancedtechnology.NASA'sunderstandingof themedical
industryand clinicalmedicine,on the otherhand,is not great. The
technologicalcompetenceof the recipientis varied. Manymedical
researchersin largemedicalcentersand teachinghospitalsare tech-
nologicallycompetent;the physiciansin clinicalpractice,in general,
are not technologicallycompetent.The manufacturerof medicalproducts
may havea longand successfulhistoryof developingand marketingmedical
productsor may be a smallaggressivecompanyexhibitinginnovative
behaviorbut lackingrelevantexperience.
The relativeimportanceand roleof each participantdependson
the technologicalgap betweenthatparticipantand the technologybeing
transferred.It is the role of the BiomedicalApplicationsTeam to
recognizethe strengthsand weaknessesof each participantand to supply
themotivation,competence,and institutionalinkagesto ensuresuccess.
Themethodologyof the BiomedicalApplicationsTeam as presentedin
section2.2 addressesthesefactors.
Technologywill be interpretedthroughout his reportas including
all of the skills,techniques,and understandingas well as thematerials,
devices,and hardwarethatmake up a specifictechnology.8 Technology
transferas usedherewill referspecificallyto horizontaltechnology
transfer. That is, the transferof technologyfrom one situational
context--theone for whichthe technologywas originallydeveloped--to
anothersituationalcontext.9 This transferwill normallyresultin
13
somemodificationof eitherthe technologyor to the situational
contextto which it is transferred.
Ruttanand Hayamihavedefinedthreelevelsat whichtechnology
lO
transfercan occur. Theselevelsare:
Levell: MaterialTechnolog_Transfer.This involvesthe transfer
Of hardwarefrom one situationalcontextto another.
Level2: DesignTechnologyTransfer. In this case both hardware
and softwaremay be transferredfor the purposeof imitatingthe
originaltechnologywith somemodificationsfor a new application.
Level3: CapacityTechnolog_Transfer. This levelinvolvesthe
transferof knowledgeand abili'tyso thatthe recipientcan
generatehis own technology.
In medicaltechnologytransfer,thereare few instancesin whicha level
I transfercan occur. The transferof physiologicalelectrodesdeveloped
for use in spacevehicles to use in clinicalmedicinerepresentsa
levell transfer.Most medicaltechnologytransfersare levels2 and 3.
Redesigningan aerospacecomponentor systemfor applicationin medicine
constitutesa level2 transfer.The utilizationof NASA-generatedknowledge,
techniques,and proceduresin the developmentand designof a new medical
productconstitutesa level3 transfer.
2.2 BiomedicalApplicationsTeam Methodology
As noted in the introduction,and indicatedin figure 3, the activities
of the BiomedicalApplicationsTeam can be separatedinto four phases.
Within each of these phases of the program, the specific actions and
responsibilitiesof the team are, to a certain extent, fixed. However,
team methodology incorporatesflexibility,which allows it to respond
appropriatelyto the specificcharacteristicsof particulartechnology
transfer cases.
2.2.1 Identificationof Opportunities
The identificationof technologytransfer opportunitiesinvolves
the identificationof (1) a medical problem or need and (2) relevant aero-
space technologythat potentiallycan solve the medical problem or satisfy
the medical need.
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The identificationof medicalproblemsoccursthroughthe direct
interactionbetweena teammemberand a researcheror physicianwithin
a medicalinstitution.At present,the RTI teaminteractsdirectlywith
medicalstaffat 27 medicalinstitutionsthroughout he easternUnited
States. Theseinstitutionsare listedin tableI.
A studyof medicaltechnologytransferby the NationalAcademyof
Engineeringand fundedby NASA has concludedthatthe recipientmust take
the lead in definingmedicalproblems.II This is consistentwith the
experienceof the RTI team. As a result,the BiomedicalApplications
Team emphasizesobtainingcompleteand extensivedescriptionsof medical
problemsand needsfrom the problemoriginatoror recipient.
Certainmedicalinstitutionsand medicalprofessionalsare more
innovativethanothers.12 Researchhas shownthatthe firsthospitals
• to adoptinnovationare generallylargemedicalcentersor teaching
hospitalsgeographicallycloseto the placewherethe technologywas
developed. Further,thosehospitalswith highlytrainedmedicalstaff
tend to be more innovative.The "innovativelite"in medicinegenerally
act to improvethe qualityof healthcare ratherthanto achievemaximum
economicefficiency.Finally,oncea hospitalhas adoptedan innovation,
the widespreaduse of that innovationis enhancedif the innovating
hospitalinteractsfrequentlywith othermedicalinstitutions.The Bio-
medicalApplicationsTeam,in its problemidentificationactivities,
considersthesefactors.
Becauseof the innovativephysician'semphasison quality,medical
technologyintroducedin the past lO to 20 yearshas tendedto increase
the sophisticationof medicaldiagnosisand treatment,but has not con-
tributedto a reductionin the cost of healthcare nor to increasingthe
qualityof healthcare for the populationas a whole.13 This indicates
that thereis an opportunityfor introducingaerospacetechnologyin a
mannerto reducethe cost of healthcare or at leastto assistin con-
taininghealthcarecosts. The effortsof the BiomedicalApplications
Team are directedtowardidentifyingopportunitiesthat potentially
reduceor containmedicalcosts.
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Technologyrelevantto medicalproblemsand needsis identified
by a varietyof techniques.Oncea medicalproblemor need is specified,
a computerizedinformationsearchof the aerospaceliteratureis per-
formedby one of the six IndustrialApplicationsCenters(IAC%). The
RTI team utilizesthe servicesof the NorthCarolinaScienceand Technology
ResearchCenterlocatedin ResearchTrianglePark,NorthCarolina. Com-
puterizedinformationsearchescan identifyinformationon potentially
relevanttechnologies.
An additionalapproachto identifyingaerospacetechnologyis the
circulationof problemstatementsto NASA fieldcenters. Individual
medicalproblemsare conciselydescribedin problemstatements.Each
problemstatementis sentto NASA engineersand scientistsworkingin
areasrelatedto the technologicalaspectsof the medicalproblem.
Responsesto problemstatementsfrom theseengineersand scientistscan
lead to the identificationof technologicalsolutions.
Finally,the BiomedicalApplicationsTeam frequentlycontactsNASA
scientistsand engineersknownto have a stronginterestin transferring
technologyto medicine. This is the most direct,efficient,and rapid
approachto locatingtechnology.The next phaseof the programis the
investigationof factorsthatdeterminewhichopportunitiesare most
likelyto be successful.
2.2.2 Screening
Effectivescreeningenables the RTI BiomedicalApplicationsTeam
to focus on those opportunitieswith the most promise for successful
medical solutionsand conTnercialproducts. In order to continue work on
a particularopportunity,the team must determine that most of the
followingrequirementsare satisfied:
• The solution improvesmedical treatmentor diagnosis or reduces
the cost of health care,
• The solution is recognizedby a medical mission agency and the
medical communityas a contributionto improved health care,
• The solution incorporatesNASA technologyor expertise,
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• The marketfor the new or improvedmedicalproductjustifiesthe
requiredcapitalinvestmentand productioncost to the manufacturer,
• A manufacturercan be offeredprotectioneitherby exclusive
licenseor by leadtime to allowsuddenentryof the productinto
the medicalmarket,
• The solutionrepresentsa discrete,well-definedtransferof
technologyinvolvinglimitedresearchand developmenteffort,and
• Candidatemanufacturerswith the requiredmarketingand production
capabilitieshave expressedan interestin commercialization.
Thesefactorsare evaluatedby reviewof the biomedical iterature,
marketsurveys,interviewswith industryrepresentatives,and discussions
with appropriatemedicalstaff. Much of the datacollectedin this
processis used in the developmentof commercialization-strategies
as describedin the nextsection.
2.2.3 CommercializationStrategies
The developmentof strategyfor successfultechnologytransfermust
considerproductdevelopmentand marketing,clinicaltrials,FDA approval
when appropriate,acceptanceby the medicalprofession,and identification
of fundingsourcesfor the varioustasksinvolved. Becauseof the emphasis
on obtainingcommercializationf NASA technology,strategiesmust involve
obtainingindustryparticipation.
The previouslymentionedNationalAcademyof Engineeringstudyof
medicaltechnologytransferreachedsome importantconclusionsconcerning
strategyfor technologytransfer.II Successfultechnologytransfer
requiresintimateand significantinvolvementof the donorand recipient
throughoutthe transferprocess. Further,the involvementof industry
throughoutthe transferprocessis essential.The mannerin whichnew
technologyis introducedto the medicalfieldis a criticalfactorin
its success;the new or improvedproductmust be acceptedby and applied
by the medicalcommunity.
The experienceof the RTI BiomedicalApplicationsTeamhas confirmed
and expandedupon theseconclusions.Industrymust be involvedthroughout
the transferprocessand must be includedasearly as possible. Further,
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the involvementof industrywill generallyrequiresomemeansfor giving
a specificmanufacturera proprietaryposition.Thismay involveeither
an exclusivelicenseor leadtime to allowsuddenentryof the new product
into themedicalmarket. Industrywill view new productopportunities
from the outsideas beingin competitionwith its own internallygenerated
productideas. Thismeansthatopportunitiesfor technologytransfer
generatedthroughthe BiomedicalApplicationsTeam Programwill have to
competefor industrycapitaland managementattention.
The acceptanceof a new productby the medicalcommunityinvolves
a fairlyspecificsequenceof events. The productmust be subjectedto
clinicaltrials,and the resultspublishedby a recognizedmedicalexpert.
Generally,the productmust be exhibitedat medicalmeetings. This sequence
normallyleadsto physicianacceptance.
Medicalmarketingand distributionfrequentlyare not an integral
functionof medicalproductmanufacturingfirms. Thus,in additionto
obtainingthe participationof a medicalproductmanufacturer,the team
must also identifyand involvean organizationcapableof marketingand
distributingthoseproducts.
Eachspecificopportunityfor medicaltechnologytransferwill offer
a new set of barriersand strategicoptions. Thus,the formationof
strategyis not a specificactivity. It is in itselfa problem-solving
effort. The most importantcommonfeatureof strategyformationis
thoroughness;all contingenciesmust be anticipated.
2.2.4 Implementationand Monitorin9
Experiencein the implementationof strategyhas shownthat the
chancefor successfultechnologytransferis increasedby activeinvolve-
ment of the BiomedicalApplicationsTeam throughoutthe transferprocess.
By monitoringand coordinatingthe activitiesof the participants,minor
problemscan be preventedfrombecomingmajorobstacles.
Reportsand documentationare an integralpartof the team
methodology;theyare involvedthroughout he technologytransferprocess.
Implementationof strategyis no exception;periodicstatusreportsare
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issued informallyto keep all participantsinformed. Upon completionof
the transfer process, the team preparesa technologytransfer report
documentingall importantaspectsof the transfer process. Sections 3.1,
4.0, and 5.0 of this report present documentationon completed technology
transfersand status reports on active technologytransfer cases.
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Their design is based directly on the NASA design. The retail cost of
the TV display modules is approximately$800.
As part of the RTI team's commercializationactivities,Dr. Clingman
performeda clinicalmarket study of the digital display device. The
total market and possible segmentationderiving from three distinct
applications were examined.
Applications
The dealer representativesuggests three possibleapplicationsof
the digitalTV displaymodule, and would segment the market accordingly.
• Use of the device as test apparatus in hospital biomedical
laboratories. It is estimatedthat all hospitalswith lO0 or more
beds would normally have such a facility,and that each laboratory
could employ one unit in repairing other equipment.
• Use of the device in cardiac stress laboratories. The device would
be used by physiciansfor real time monitoring of patientsduring
testing. Digital capabilitywould enable the monitoringof more
EKG channels and the memory storageof desiredsectionsof each
trace for referencing. Further study and selectionof EKG traces
before making hard copies would be possible. All 300 bed or larger
facilitiesare estimatedto have such a stress laboratory.
• Integrationof the module into monitoring systemswhere it is
desirable to digitize patient informationfor computer input and
diagnosis. An existing trend in this direction is projectedto
continue and accelerate in hospitalswith 500 or more beds.
Monitoring systemswould requiremultiple unit installationof the
device.
Market Segment Evaluation
For the developmentof broad marketing strategy the dealer
representativemade these evaluations.
• Biomedical laboratoryusage of the device essentiallyas a test
instrumentis not likely to develop substantialcustomer interest.
As such, this segmentwould not support the investmentnecessary
to support the primary sales effort.
• Cardiac stress laboratoriesare generallycapable of the budget
outlay necessaryfor the module. Additionally,the testing
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capabilitiesof the device in this area would be income producing
for the customer. This is viewed as the primary target for sales,
with opportunityfor immediatereturn. Possibilitiesin this
market segment are the principalmotivator for involvementof the
dealer firm.
• Integrationof the module into patientmonitoring systems is
viewed as an emerging,yet future marketing opportunityinvolving
different sales techniquesand support,as well as additional
interfacecapability.
Table 2. Digital TV Display Market Analysis,National Market
Market Number of Number of DisplayUnits Total Units
Segment Beds Hospitals per Hospital
J_
#1 I00-299 2370 l 2370
#2 300-499 745 2 1490
#3 500 or more 608 2 1216
Total Units 3723 1.36 5076
Table 3. Digital TV Display Market Analysis,LouisianaMarket
Market Number of Number of Display Units Total Units
Segment Beds Hospitals per Hospital
#1 I00-299 50 l 50
#2 300-499 12 2 24
#3 500 or more 8 2 16 .
Total Units 70 1.29 90
These clinical applicationsof the display device appear promising.
Before this secondmarketing area can be entered, however, two tasks
remain: (1) to redesign the display unit for clinical use and (2) to
establish an agreementbetween the electronicsmanufacturerand the
medical device distributorfor the productionand marketing of the
clinical unit.
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3.2 The NASABlack Bag: An Analysis of the Commercialization Potential
Objective and Methodology
The objective of this study was to evaluate the commercialization
potential for the physicians' black bag that has been developed by the
NASAJohnson Space Flight Center. The study was done through interviews
of potential users in a number of key areas. The potential for com-
mercialization depends both on the number of units that could be put into
use as well as the desired configuration of those units by each user
group. Thus, our objective was different from measuring the market size
for a specific NASAproduct. Our objective was to develop a product
description within general constraints that would have a sufficiently
large market to achieve commercialization.
The general product description that was used in this study is given
below_ The product is essentially a physician's black bag containing a
number of optional electronic and nonelectronic modules. These are
primarily for use in emergency situations. One of our objectives was to
determined the optimum modules to include to achieve commercialization.
NASAJohnson Space Flight Center has built a prototype of the bag.
The contractor was Telecare in Houston. They were interviewed in this
study and were interested in commercializing the black bag, provided a
sufficient market could be identified.
The potential market could be divided into four sectors. These were
emergency medical services, physicians, institutions, and government. The
development of the product description within each sector was carried out
through interviewing potential end users. For the most part, these were
people who would make the purchase decision in each sector. Within the
general constraints described below, there was a free discussion of what
the product should be. Within each sector conclusions were then drawn as
to what product specifications should be. Published statistics were then
used to estimate the market for that product.
The four market sectors are discussed below, and the overall con-
clusions are given in the final section of the report.
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ProductDescription
The blackbag was presentedas a suitcasethatcontainsoptional
moduleswhichare electronicand nonelectronic(Figure5). The modules
are listedin Figure6. Not all of thesewouldbe presentineveryblack
bag. Thesepackagesare intendedto providethe instruments,expendibles,
and drugsthatwouldbe requiredin an emergencysituation.
The electronicmodulescan be dividedintothreegeneralcategories.
Firstis themonitoringof vitalsignssuchas heartrate,bloodpressure,
etc. Secondis a defibrillator,and thirdis commercializationequipment.
Illustrationsof the productwere obtainedfrom Dr. LaPintaat Johnson
SpaceFlightCenterand were used in the interviews.
In the interviews,it was emphasizedthatthe particularmodules
shownwere onlymeantto be examples. The interviewerexplainedthat the
primaryNASAcontributionwas miniaturizationof themodules,thereby
achievingpotentialweightand cost savings. The totalweightand cost of
the package,however,woulddependon the numberof modulesincluded. The
more functionsthat couldbe performed,the higherthe weightand cost. The
interviewdiscussionsfocusedon the specificattributesthatwouldbe
neededfor that end user to purchasethe product.
MarketSectors
Dr. LaPintaat JohnsonSpaceFlightCenterand RaymondWhittenat NASA
Headquartershad exploredseveralpotentialapplicationareaspriorto this
study. Presentationshad beenmade to variousgovernmentgroups,such as
the U.S. Navy,and the prototypehad been exhibitedat AMA meetings. Based
on the responseobtained,fourmarketsectorswere selected. Thesewere
emergencymedicalservices(EMS),physicians,institutions,and government.
In coveringeach of thesesectorsapplicationswere limitedto emergency
use of the blackbag. The sectorsdifferprimarilyin who wouldpurchase
the product.
In the EMS sectorthe purchaserwouldusuallybe a localgovernment
agencythat is operatingthe ambulanceservice. Itmay be the fire or
policedepartment;it may be a volunteergroup;it may be a local
hospital. In thesecasesthe personmakingthe-purchasingdecisionwould
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be the administratorof the agencyoperatingthe emergencymedicalservices.
If advancedEMT'swere employed,then it was foundthattheywouldalso
make a significantcontributionto the selectionof equipment.
In the physiciansectorthe purchasewouldbe made by a physicianin
privatepractice. Thosewith urbanand ruralpracticeswere interviewed.
In the institutionsectorthe potentialcustomerswouldbe industrial
clinics,hospitalemergencyrooms,etc. Finally,the governmentsector
wouldcomprisethoseunitspurchasedby the U.S. Government.In this
case,interviewswere conductedwithinthe military,FAA,and the Peace
Corps.
Conclusions
In eachmarketsectorthe desiredproductwouldcontaina defibril-
lator,and in most casestherewouldbe littleinterestin the nonelectronic
modules. The largestsinglemarketareawouldbe the military. Theywill
be purchasingthe equivalentof severalthousandblackbagsover the next
. 2 to 3 years. Thereis also a firmmarketin the EMS sectorof about300
unitsa year. Thesesaleswouldbe associatedwith the upgradingof
ambulancesfromEMT to advancedEMT capability.In both the EMS and
militarymarkets,thereis a need to competewith otherequipmentby
achievinglighterweightor lowercost. Thereis only a smallfraction
of physiciansthatwouldpurchasethe blackbag. Less certaintycan be
attachedto the estimatebecauseof the smallnumberof interviewscarried
out. It is probablyof the orderof a few hundredunitsperyear. These
wouldbe sold to ruralphysiciansmakinghousecallsin sparselypopulated
sectionsof the UnitedStates.
InstitutionalMarket
The conclusionsdrawnfrom the interviewswas thatthismarketsector
was very small. No institutionwas foundthatwouldbuy any modification
of the NASAblackbag for institutionaluse. The only purchaseby an
institutionsuch as a hospitalwouldbe for use on a vehicle.
In a hospitalemergencyroom or clinictheywouldhave a "crashcart"
thatalreadyhas storedon it the componentsneededfor emergencies.This
servesthe same functionas the blackbag. Fromthe viewpointof the
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hospitaladministratorthe crashcart has advantages.Most important
is thathe can controlthe unitratioof componentspurchased.In a multi-
cart environmenthe is not artificiallyconstrainedto obtainingsome
componentswhichhe does not need in orderto obtainothersthat he does
need. Anotherperceivedadvantageof the crashcart is thathe can
optimizethe selectionof each individualcomponentand not be confined
to just one supplier. This is alsoan advantagefrom the viewpointo_ the
physicianperformingemergencyservices. The physiciansinterviewedwere
concernedover the reliabilityof the NASAblackbag becauseof the
miniaturizationof the electronicmodules. Withoutan overridingadvantage
to them in the blackbag,theywouldtend to purchaseequipmentthat has
been on the marketfor some timeand withwhichtheywere familiar.
GovernmentMarket
Thereis a significantmilitarymarketfor the purchaseof eitherthe
NASA blackbag or an equivalentset of components.The Navy is now pur-
chasingthe separatemodulesthatcouldgo intoa blackbag. This includes
a defibrillator,monitor,and nonelectronickits. The NASAblackbag
prototypehas beenshownto theNavy on at leasttwo occasions.The most
recentwas in Augustwhen Roy Gage,Dr. LaPinta,and Dr. Clingmanvisited
Dr. Mantelin the NavyBureauof Medicineand Surgery. Roy Gage is
Presidentof Telecare,a manufacturerof EMS equipmentand the NASAcon-
tractorwho builtthe prototypeblackbag. Dr. LaPintais with the NASA
JohnsonSpaceFlightCenterand participatedin the developmentof the
bag. Dr. Mantelis responsiblefor selectionof all medicalequipment
thatwill be purchasedby the Navy. He likesthe NASA blackbag concept
and wouldpurchaseit todayexceptfor two factors. He needsa defibril-
latorin the unit but thiswas not includedin the prototype.He also
needsa finishedproductthat is availablefor purchase.
Dr. Mantelis now buyinga Life-Pac5 defibrillatorand monitor. He
is combiningthesewith othermodulesto form the equivalentof the NASA
blackbag. He is assemblingtheseunitsat the rate of 300-700per year.
Theseare for shipboardapplicationsin emergencysituations.Afterthe first
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2 yearstheymay purchaseanother1,000-2,000unitsfor additionalappli-
cations. Thereis an interagencycommitteethatcoversthisequipment.
Dr. Mantelsaid thathis colleaguesin the Army and Air Forceare waiting
to followtheirleadin the Navy. Thus the totalmilitarymarketover the
next 5 yearscouldbe severalthousandunits.
Dr. Clingmanalso interviewedby telephoneboththe PeaceCorpsand
FAA,wherepriorinteresthad beenexpressedin the NASA blackbag. At
the PeaceCorps,he talkedwith Dr.AlvinAliowho said that,as a matter
_f policy,they provideno diagnosticor emergencymedicalservicesin the
hostcountry. Theironly requirementfor a blackbag is in the treatment
of theirown volunteers.Therewouldbe a maximumof about50 units
required. Dr. Alio firstsuggestedthat themanufacturercontacteach of
the physiciansin chargeof a fieldsectionand sellthe blackbag directly
to him. In discussingthis pointfurtherhe did say that it mightbe
possibleto sella groupof bagsto a centralpurchasingfacilityof the
PublicHealthService.
The FAA interviewwas with Dr. StanMohler. He had seen the black
bag, and in his opinionthereshouldbe one on everycommercialaircraft.
He said thattherenormallywouldbe a physicianon boardwho coulduse
the equipment.He alsosaid that therewere a numberof heartattacks
eachyear on commercialflights. Accordingto Dr. Mohler,the problemis
that the airlineswouldresistpurchaseof the equipment.It wouldhave to
be done throughregulation,and the politicalenvironmentwouldprevent
this for sometime to come. FAAmanagementfeelsthatthereare many other
areasof higherpriorityrequiringnew regulations.
Thus the principalgovernmentmarketis in the military,and this is
the largestof the marketsectorsevaluated.At thispointin time the
marketis a few thousandunits. The marketis decreasingwith time,and
in 2 to 3 yearsthe prospectwouldbe many fewerunits. Thus,a rapid
entryinto thismarketwith a NASAdevicewouldbe significant.
EmergencyMedicalServices
Some generalconclusionscouldbe drawnfromthe interviews.First
of all, for the NASA blackbag to be used on an emergencyvehicle,there
wouldneed to be advancedEMT'sassignedto the vehicle. The marketwould
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be associatedwith thosevehiclesbeingupgradedwith equipmentfor
advancedEMT's. Such equipmentwouldincludea defibrillator,for
example. Once the vehiclewas upgraded,thenno interestwas foundin
replacingexistingequipmentwith the NASAblackbag. Thus,the annual
marketwouldbe limitedto thosevehiclesthat are upgradedduringthe
next year.
A secondconclusionwas that,in upgradinga vehicle,a necessary
componentwas a defibrillator.The primaryadvantageof the NASA black
bag as seenby thoseinterviewedwas a lowerweightor lowercost through
miniaturizationand a combinationof functions.The defibrillator-
monitorcombinationis wherethe primaryinterestis forweightreduction.
Littleinterestwas foundin purchaseof the vitalsignsmonitorsalone
from the blackbag_ Therealsowas no interestin the nonelectronic
modules. Drugscarriedon the vehiclehave to be sealed,checkedout of
the hospital,and separatelycontrolled.The bandages,instruments,and
othernonelectronicitemsarealreadyavailablein kitssellingat $700-
800. Many of the paramedicsinterviewedput togethertheirown kitsand
wouldwant to maintaincontrolover the selectionof the contents.
If an electronicpackagecouldbe providedthatcontaineda defibril-
latorand offereda weightand/orcost advantage,thenkeen interestwould
be found. The potentialannualmarketwouldbe all ambulancesupgraded
or addedwith equipmentfor advancedEMT's. An estimateof the numberof
such unitswas made usingstatisticsobtainedfromthe congressionalhearings
on EmergencyMedicalServicesand Burn Facilities,HouseSubcommitteeon
Healthand the Environment,January27, 28, and 29, 1976.
The followingstatisticsare for theyear 1976and indicatethe rate
at whichFederalmoneywill be spentin upgradingambulanceservice. This
is the key to determiningthe availablemarketfor blackbags. In 1976
therewere 27,500ambulancesin operation.Thiswas consideredto be
aboutthe propernumberneededby DOT. Only about20 percentof thesemet
DOT-GSAspecifications.About80 percentof the ambulanceswouldbe
replacedby 1981. Therewere 14,300ambulanceservices. Of these,
20 percentwill be convertedto advancedEMT statusovera 5-year
period. Of thoseservicesbeingupgradedtheywill have on the average
four ambulances,two hospitals,and one repeatingstation. Therewere
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also plans to upgrade about 20 percentof the EMT's to advanced EMT status
over the same 5-year period.
One conclusions from the interviewswas that purchase of the NASA black
bag would be no different in rural or urban areas. Thus, from the above
statistics it follows that about 2300 vehicleswould be upgraded per year.
This would be the availablemarket for the black bag. It would seem that,
because of competition,m aggressivemanufacturermight gain 20 percent of
this market or about 460 units per year.
Physicians
In all of the face-to-faceinterviewsno physicianswere found who
said that they would purchase a NASA black bag. Those contactedwere in
family practice, some in a rural and some in an urban setting. Those in
the urban practice feel that in an emergencytheir first concern would be
to move the patientas rapidlyas possible to a hosptial. They would be
reluctant to use a defibrillatorthemselveswithout trained technicians
present. They felt that use of the vital signs monitors would just delay
transfer of the patient to the hospital. No urban physicianswere found
who make house calls or know anyone who makes house calls.
The doctors in rural practicewho were interviewedhad the same com-
ments. They had the further disadvantageof patientswho could not afford
the use of special equipment. Even though the travel time to a hospital
emergency room might be 30 minutes, the desire was still to move the
patient to the hospital as soon as possible. Some rural physicianswere
interviewedwho previouslyhadn_dehouse calls in their careers. They said
at that time they could have used the NASA black bag.
Telephone interviewswere carried out by Earl Herron of nine physicians
in rural practice. These are listed in Table 4 along with an indication of
the result. When the physicianwas in a sparselypopulatedarea, there
was interest. Thus, it is assumed that some fraction of these physicians
could be sold the black bag.
There is some statisticalinformationon the number of house calls being
made. House calls in rural areas for a number of years are shown in Table
5. If doctors were making these house calls, then this would average lO00
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Table 4
TelephoneInterviewsof RuralPhysicians
Conductedby Earl Herron
Location CountyPopulation CountyArea Response
Prentiss,Mississippi 12,936 414 sq.mi. Negative
Thephysician'spolicy isto sendemergencycasesdirectly to the hospital
Brattieboro,Vt. 33,476 784 sq. mi. Negative
The physicianwas worried about malpracticesuits arisingfrom use of the black bag
Havre,Montana 17,358 2,700 sq.mi. Negative
" Theunit includingthe defibrillatoristoo expensive($6,000-$7,000)
Glendive,Montana 11,269 2,370 sq.mi. Negative
The physicianmight havepurchasedthe black bag five yearsago but now hispolicy is
that patientsgodirectlyto the hospital.
Bend,Oregon 30,442 3,031 sq.mi. Positive
They would purchaseone without the defibrillator ($1,500) for hospitalemergencyuse
Rawlins,Wyoming 13,354 7,905 sq.mi. Negative
Thesheriffgoesdirectlyto the hospitalwith the ambulance
Thermopolis,Wyoming 4,952 2,022 Positive
The physicianmakes housecalls and was interestedbut he thought it was expensive
Flagstaff,Arizona 48,326 18,540sq. mi. Positive
Thephysicianwasinterestedandsometimesgoesto thesceneof an accident
Madison,WestVirginia 25,118 501 sq.mi. Negative
There are two smallhospitalscloseto the physicianand he alwayshasthe patienttrans-
ferreddirectlyto theclosest.
,.
Table 5
NumberofPhysicianVisitsOutsideofSMSA
('ooo)
Placeof Visit
Year Office Home Hospital Company Telephone Other
1966- 205,774 6,610 22,563 (1) (1) 33,487
1967
1971. 237,733 4,696 26,964 1,632 36,519 13,267
1973- 210,749 (1) 26,748 (1) 29,504 19,485
1974
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each or 2-3 a day. Thus 4,700unitsis considereda lowerlimiton the
potentialmarketsize. Actualsaleswouldbe some fractionof this
significantmarket,but the marketis not expectedto be a largesector.
Conclusions
The totalavailablemarketfor the NASAblackbag over the next 5
years is severalthousandunits. Theseunitswouldneedto containa
defibrillator.The largestsectorof thismarketwas the military,but
it will probablybecomesaturatedoverthe 5-yearperiod. The second
largestsectorwas emergymedicalservices. Aggressivemarketingcould
generatesalesof about400-500unitsperyear. Time is importantin
pursuingboth of thesemarketsectors.
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4.0 INSTITUTIONALTECHNOLOGYTRANSFERS
Duringthe reportingperiod,six institutionaltechnologytransfers
were completed: EMG SpectralAnalysis,Enhancementof X-RayDiffraction
Images,Lung SoundModeling,OpticalProfilometer,SCA Receiverfor the
Handicapped,and Multi-LevelCareManagement.Whilethesetransfershave
not resultedin new medicalproducts,they representsignificantcontri-
butionsto healthcaremanagementand research. One transfer,the SCA
Receiverfor the Handicapped,has potentialfor futurecommercialization.
Thesesix transfersare documentedin the followingpages. The
medicalapplications,NASAtechnologies,the transferprocess,and major
participantsare identified.
EMG SpectralAnalysis
BATeamPersonnel: Dr. RichardScearce
The rapidexpansionof marineresourcedevelopmenthas stimulated
man's interestin deepseadiving. The rush to exploitoffshoreoil
depositsis one example. A well cannotproduceuntila diveron the
ocean'sfloorhas attachedthe pumpsand valving. Thus,offshore
drillingrequiresscubadiversto liveand work at depthsof 700 to
lO00 feetof water. Drillingcompanieslowerhabitatsto the oceanfloor
whereseveraldiverslive forweeks. Unfortunately,researchhas dis-
coveredthatman developstremorsat depthsof lO00feet of water,and
at 1500feet,man experiencesmicrosleep--momentarylapsesintodeep
sleep. Eitherphenomenoncouldcausean accident,whichat thosedepths
wouldbe fatal. Unfortunately,thesephenomenaare not understood.
The problemoriginator,Dr. MichaelAckerman,is studyingthe
physiologicaleffectsof deepseadiving. In his research,he instruments
animalsand placestheminto pressurechambersto simulatedeepdives.
One measurementof particularinterestis the electromyogram(EMG).
Dr. Ackermanplansto do a spectralanalysisof the EMG data to detectthe
subtlechangesin frequencycontentthatare the firstsignsof the onset
of tremor. The researcheraskedthe teamwhetherNASAhad developed
computersoftwarefor thispurposethathe coulduse in his divingstudies.
In 1976,a NASA contractorat JohnsonSpaceCenter(JSC)published
a specialreporttitledA ComputerProgramfor Time and FrequencyDomain
Reductionof ElectromyographicData. A teammembercontactedthe authorand
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discussedthe program. It was evidentthe programwas exactlywhat the
problemoriginatorwanted. Computerlanguagewas no problem,sincethe
JSC computersystemwas identicalto Dr. Ackerman'scomputersystem.
In December1978,the authorrecordedthe programonto a magnetic
tape for Dr. Ackerman.
This directapplicationof NASA softwarehas significantlyreduced
the time and the costof completingan importantresearchprojecton the
physiologyof deepseadiving. Thus,aerospacetechnologyhas contributed
to the understandingof man'sresponsein yet anotherenvironmentin
preparationfor the safeharvestingof marineresources.
Enhancementof X-RayDiffractionImages
BATeamPersonnel: Dr. ClarkBeall
NASA technologyfor the recoveryof grosslyunderexposedphotographic
imageshas beenappliedby the RTI team to improvethe qualityof X-ray
diffractionimages. The NASA techniquealso enablesa researcherto
reducedrasticallythe experiment ime requiredfor the recordingof a
satisfactoryX-raydiffractionimage. Researchersat Duke University
MedicalCenterhaveacceptedthe conceptof the NASAautoradiography
techniqueand are purchasingthe equipmentnecessaryfor producingthe
autoradiographs.Ms. BarbaraAskins,of MarshallSpaceFlightCenter,
has providedthemwith comprehensivedocumentationof the technique.
The researcherplansto evaluatethe NASA techniquein severalresearch
applications.
Lun9 Sound Modelin9
BATeam Personnel: Ms. Doris Rouse
Disabling pulmonaryillnessesmay result from a variety of causes
includingenvironmentalfactors,pulmonaryvascular pathology, asthma,
and cystic fibrosis. Researchershave examined the structure and function
of the normal lung as well as the mechanisms by which alterations in a
respiratory functionmay lead to disease. In many pulmonarydiseases,
especially lung cancer, early detectionand accurate diagnosiscan enhance
the success of the treatment.
In 1971, Dr. F. T. Wooten of the RTI team worked with Dr. W. W. Waring
at Tulane School of Medicine on a projectto improvediagnosis of
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respiratorydiseaseby lungsounddetection.The team introducedthe
problemoriginatorat MCV, Dr. John Patterson,to Dr. Waring. As a result,
a usefulexhangeof techniquesand researchresultstookplace.
Dr. Jay Hardin,of theAcousticsDivisionat LangleyResearchCenter,
is workingwith the problemoriginatorto employsoundanalysistech-
niques,lungairflowparameters,and a lungmodelto determinethe
locationand natureof the alterationsin lungstructureresponsible
for compromisedlungfunction. Dr. Hardinand Dr. Pattersonpresenteda
paperentitled"Theoryof SoundGenerationin the HumanLung"at theMid-
AtlanticConferenceon Bio-FluidMechanicsin August1978.
The teamwill continueto provideDr. Pattersonand Dr. Hardinany
assistancetheymay requirein thiscontinuingproject.
OpticalProfilometer
BATeamPersonnel: Dr. RichardScearce
Cleftlip or palateoccursin l of every600-700births. Surgical
closureof the cleftis required. Orthodontistsmustcarefullyschedule
this surgicalfusionof the bone segmentsso that normalgrowthand
developmentare possible. The propertimefor the surgeryis determined
by a carefulexaminationof the palatesize,shape,and growthpatterns.
To obtainthesedata,the orthodontistformspermanentcastsfrom
impressionsof the palatetakenperiodicallyfrom infancy. The ortho-
dontist'streatmentplanis basedon his analysisof the castsusing
calipersand measuringtapes. The inabilityof thesemeasuringtechniques
to describethe complexthree-dimensionalsurfaceof the palatecasts
meansthatsubtlechangesin shape,size,and volumeof the palatego
undetected.Thus,a systemcapableof quantitativelysurveyingthe
complexcast'ssurfacewouldenableorthodontiststo improvetheirunder-
standingof the morphologyof the cleftpalateand theirtreatmentplans
for thisfacialdeformity.
The problemoriginator,Dr. SamuelBerkowitz,developeda stereo
photographysystemand utilizedstandardmappingtechniquesto quantitate
the complexsurfacesof the palatalvaultcastmore precisely.The
resultsof his analysisof many castsdemonstratedthe utilityof this
additionalinformationin the treatmentof cleftpalate.This stereo
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photographytechnique,however,was too costlyto competewith con-
ventionalanalysismethods.
In responseto an RTI team problemstatement,engineersat Langley
ResearchCentersuggestedthat NASA'sautomaticfocuscontrolsystemfor
a facsimilecamerabe modifiedto measurethe cast surface. This focus
controlsystem,used on theVikingLander,automaticallycompensatesfor
changesin the distanceto the photographedobject. A modificationof
the Vikingsystemhas resultedin a relativelysimpleand inexpensive
opticalprofilometer.
The opticalprofilometerprovidesthe digitaldata necessaryto
characterizethe small,complexthree-dimensionalsurfacespresentin
palatalcasts. To obtainthis information,the opticalsystemcorrelates
the changein energydistributionof reflectedlightwith surfacedepth
at the pointof reflection.Variationsin surfaceslope,}urface
reflectanceand lampintensitycauseunwantedchangesin the output
signal. Theseerrorsare significantlyreducedby normalizingthe sample
photodetectoroutputto a referencephotodetectoroutput.
In December1978 the completedprofilometerwas shippedto Dr.
Berkowitz.He is collaboratingwith the ten leadingcleftlip and cleft
palatecentersto developa researchrecordsystemfor craniofacial
anomalies.The opticalprofilometerwill be utilizedas the primary
data collectiondevice. Thousandsof palatalvaultcastswill be analyzed.
The resultingnumericaldatawill be accumulatedin a data file to be
used both as a researchand a clinicaltool. By studyingthe data,
researcherswill learnmore aboutthe subtlesurfacechangesthat take
place. By comparingcastsof new patientswith data fromprevious
patients,the orthodontistwill be able to recommendthe optimaltreatment.
Thus,thisapplicationof NASA-developedtechnologywill providea
vastlyimprovedquantitativevaluationof morphologicalsubtleties
whichwill enablemedicalpersonnelto improvethe treatmentof this
facialdeformity.
SCA Receiverfor the Handicapped
BATeamPersonnel: Dr. ClarkBeall
In 1975 the FederalCommunicationsCommissiongrantedpermissionfor
the use of audiomachinecode programmingon the SCA (SubsidaryCommuni-
cationAuthority)subcarrierof commercial'FMradiostations. Organizations
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for the deaf are interestedin utilizingthe SCA subcarrierfor the trans-
missionof RadioTeletype(RTTY)programsin largeurbanareas. The audio
tonesthatcomprisethe RTTY transmissionsare exactlythe same tonesthat
are generatedand decodedby the phonecouplersthatare alreadywidely
used by the deaf for telephonecommunicationby Teletype. All that is
neededfor thesehomesto be ableto receivethe RTTY broadcastsis the
additionof an SCA subcarrier eceiverat each site. The SCA subcarrier
receivers(designedfor commercialSCA systems)are too costlyfor large
scalepurchasesby the deaf.
Utilizingphase-locked-looptechnology,engineersat the Goddard
SpaceFlightCenterhavedesignedand builta circuitboardthatenables
a low cost,commerciallyavailableFM radioto receivethe SCA RTTY
broadcasts.In November1977a teammembervisitedGoddardSpaceFlight
Center,pickedup this radioand took it to the 'Philadelphiaarea for
a fieldtest. The FM stationof TempleUniversity,in downtownPhiladelphia,
broadcastsSCARTTY twicedailyfrom programmingmaterialprovidedby the
PennsylvaniaSchoolfor the Deaf. This RTTY systemis the first,and at
the presenttime,the only RTTYsystemfor the deaf in the UnitedStates.
TheseRTTY broadcastsare receivedby more than30 deaf familiesin the
GreaterDelawareValleyarea. More than300 familieswill eventuallybe
equippedwith SCA receiversin thisarea. In the Philadelphiatestof
the NASA SCA receiver,the receptionwas satisfactorywith the set at a
distanceof lO miles fromthe transmittersite,even thoughthe set was
equippedonlywith a whip antenna.This rangeshouldbe more thandoubled
when the receiveris attachedto a properlyoriented,directionalTV or
FM antenna.
In orderfor commercializationf the SCA receiverto proceed,more
demandmust be generatedby the developmentof more RTTY systemsin the
largerurbanareas. Thereare severalreasonswhy more of the RTTY systems
for the deaf do not existin the UnitedStates. First,most of the local
organizationsof the deafare not awareof the possibilityfor initiating
a localRTTY system. Second,if the localorganizationdoes not have
technicalpersonnelreadilyavailable,theyare intimidatedby the technical
aspectsof the project. Third,the costof purchasinga largenumberof
commercialSCA receiversis too great. Finally,a cooperativelocalFM
stationis not alwaysavailablefor transmittingthe RTTY.
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Multi-LevelCareManagement
BATeamPersonnel: Dr. RichardScearce
Dr. John D. Chase,formermedicaldirectorof the VeteransAdmini-
stration,describedthe Multi-LevelCare (MLC)Programas the "most
significantprojectVA has launchedin the lasthalfdozenyears." Faced
with increasingcostsand growingdemandsfor healthcare services,the
VA designedthe MLC programto: (1)improvethe qualityof healthcare
by organizingthe resourcesof the VA'smedicaldistrictsand health
care facilities o as to focuson the healthcare needsof the individual
patient,(2) improvethe financialmanagementsystemby modifyingexisting
budgetary,resourceallocation,and cost-controlmechanismsat VA central
office,district,and facilitylevels,and (3)providean improvedbilling
and reimbursementsystem. To accomplishthis the MLC Programis divided
into 15 levelsof care. Each levelof care is definedby the type,number,
and intensityof physician,nursing,and supportstaff,space,beds,and
equipmentorganizedto meet a definedrangeof patients'needs. Cost
accountingis alsodividedalongthesesame levels. Thus,underthis
system(seeFigure7) a physicianplaceseach new patientat a levelof
care accordingto preestablishedcriteria. As an example,if the patient
requiredin-hospitalmedicaland surgicalservices,the physicianwould
assignthe patientto one of five levelsof care: intensive,acuteI,
acuteII, extendedhospital,or minimal. As the patient'sneedschange,
the staffwouldshiftthe patientto the appropriatelevel.Since cost
accountingis alsodividedby levelof care,the billwouldreflectthe
numberof daysat each level.
Dr. Karl Eurenius,directorof the MLC Program,planstwo trial
implementations.Each trialwill involvetwo VA medicaldistricts. If
thesetrialsare successful,the MLC Programwill be implementedin the
remaining24 VA medicaldistrictsby 1982.
Dr. EureniuscontactedNASAheadquartersto ask if any of NASA's
projectmanagerscouldassisthis staff. He felt thatmanagingthis pro-
grammightbe very similarto managingone of NASA'slargemultidiscipline
projects.
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Figure7. PatientF1owin a Multi-LevelCare System
Someyearsbefore,the teamhad workedwith ColonelLee B. James.
ColonelJames,who is retired,had held numerousNASAmanagementpositions.
Theseincludeddeputydirectorof the ApolloProgram,directionof
programmanagementat MarshallSpaceFlightCenter,directorof the
SaturnProgram,programmanagerof the Saturn5 Programand program
managerof the Saturnl and IB programs. He had also been a professor
of cyberneticsat the Universityof Tennessee,wherehe wrotea book
entitledManagementof NASA'sMajorProjects.
In April1978,the team contactedColonelJames,describedthe MLC
programto him,and explainedthat Dr. Eureniushad requestedmanagement
assistance.ColonelJamesagreedto investigatethe situation.Thus
the team arrangedfor ColonelJamesto attendan MLC programconference
held in Cincinnati,Ohio,on AprillO-12,1978. The conferenceinitiated
the firsttrialimplementationof the MLC Program. Attendingwere the
hospitaladministratorsand chiefsof stafffrom lO VA hospitals.On the
finalday of the conference,ColonelJameswas askedto presenthis
observations.He spokefor approximately30 minutes,and demonstratedan
amazinggraspof the programand the obstaclesto its implementation.
Immediatelyafterthe conference,Dr. EureniushiredColonelJames
as a managementconsultant.Subsequently,he has helpedplan and execute
an evaluationof the earlyMLC trials. ColonelJamesis presently
assistingDr. Eureniusand his staffin the program'slong-rangeplanning.
Both Dr. Eureniusand his deputyhave personallythankedthe team
for introducingthemto ColonelJames. Becauseof his experiencein
directingNASA'slargemultidisciplineprojects,he has been able to
quicklyidentifyproblemareasand help the VA teamavoidunnecessary
delays.
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5.0 STATUSOF ACTIVE TRANSFERPROJECTS
The Biomedical Applications Team is investigating 27 transfer
projects at the present. These projects include 12 medical problems
identified during the reporting period and 15 identified prior to
1 January 1978.
Of the 27 active transfer projects, all but one have the potential
for becoming commercialization technology transfers. This is a direct
result of the emphasis by the RTI team on the potential for com-
mercialization in the team's identification of opportunities and
screening activities as described in section 2.0. The approach of
the team in obtaining widespread utilization of NASAtechnology is
to direct its efforts primarily to solving problems that involve
the introduction of a new or improved medical product. It should
be noted that the team does not exclude opportunities for applying
NASAtechnology in medical research.
Seventeen new problems were identified during the reporting period.
Problem statements describing these new problems are presented in
Appendix B. Reports on those new projects that are still active are
included in this section.
Four of the active transfer projects reported here have been
reported as institutional technology transfers in previous final
reports. In these instances, the team has recognized opportunities
for commercialization transfers, and is taking appropriate action.
Problems in this category are:
Neuropathic Tester
Weight Alleviation Device
Controlled Rate of Freezing a Liquid
Pressure Transducer Calibrator.
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Breast Cancer ScreeninqTechnique
BATeam Personnel: Dr. Richard Scearce
In 1975,Dr. JohnN. Wolfeof Detroitdescribeda techniquefor
predictingwomenlikelyto developbreastcancer. Basedon the breasts'
radiographicappearance,Dr. Wolfecan classifywomenintorisk
categories.Othermedicalgroupshave verifiedthe technique.Un-
fortunately,the methodrequiresa highlytrainedradiologisto study
each mammogram.Thus it wouldbe impracticalto use this techniqueto
screenthe IO0millionwomenin thiscountry. Sucha taskrequiresan
automatedmethod.
RobertButterfieldof KennedySpaceCenterdevelopedimagepro-
cessingmethodsfor analyzingradiographicand ultrasoundimagesof the
breast. He designedhis processingmethodsto automaticallyperformDr.
Wolfe'spredictivetechnique.Mr. Butterfieldrequestedthe team's
assistancein developinga strategyto evaluateand commercializehis
image-processingmethods.
Interviewswith medicalresearchersand a reviewof the literature
verifiedthe importanceof Dr. Wolfe'swork,the needto automatethe
technique, and the need for this analysis system to be applicable to
both ultrasoundand X-raymammograms.In May 1978a teammemberand Mr.
Butterfieldvisitedthe problemoriginator,who is directorof the
Divisionof DiagnosticUltrasoundat ThomasJeffersonUniversityHospital.
Duringthe vist they arrangedfor an evaluationof the ultrasound
image-processingmethods. The problemoriginatoror his assistantwill
visitKennedySpaceCenterin February1979 to initiatethisevaluation.
The teamalsocontactedpersonnelat Duke University'sBreast
CancerScreeningCenter,whereresearchershad verifiedDr. Wolfe's
predictivetechnique.In a controlledstudyof 171 X-raymammograms,
theirresultsagreedwith Dr. Wolfe'sfindings. The team is completing
arrangementswith the Dukemedicalgroupfor the evaluationof Mr.
Butterfield'sX-raymammographyimage-processingmethods. An initial
testset of mammogramswill be forwardedto KennedySpaceCenterin
january1979.
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CompositeMaterialApplications
BATeamPersonnel: Dr. RichardScearce
AlthoughNASA has demonstratedthe feasibilityof utilizingcomposite
materialsin orthotics,to achievewidespreadutilizationof thistechnology
two tasksremain: (1)the identificationof additionalappropriate
applicationsof composites,and (2) the developmentof manufacturingtech-
niquessuitablefor use in the orthoticshop. MississippiMethodist
RehabilitationCenterhas receiveda contractfromLangleyResearchCenter
to meet theseobjectives.
At the requestof the directorof engineeringat the rehabilitation
center,Dr. Scearcemet with RobertM. Baucomand SheilaT. Longof
LangleyResearchCenterto discussan evaluationof the qualityof the
compositesproducedin the MississippiMethodistRehabilitationCenter
Shop. Mr. Baucomhas agreedto validatethe qualityof samplesfromthe
rehabilitationcenter.
Progresshas beenmade thusfar in the identificationof new appli-
cationsand developmentof manufacturingtechniques.The team is working
closelywith LangleyResearchCenterand the rehabilitationcenterin
assessingthe commercialpotentialof theseapplications.
ControlledRate of Freezinga Liquid
BATeamPersonnel: Dr. RichardScearce
The treatmentof several forms of cancer and certain other diseases
requires the infusionof large quantities of stem cells or other blood
components (e.g., red cells, white cells). To obtain the necessary
quantities,the cells are collected, frozen, and stored for later use.
Unfortunately,many of the cells are damaged by the traditionalfreezing
process. Some authoritiessuggest that the nonlinearrate of freezing_
causes the damage. "
Jet PropulsionLaboratory (JPL) personnelhave suggesteda technique
that would detect the onset of freezing and would increase theheat "\
transfer rate during the release of latentheat so that a nearly constant
rate of freezingwould be maintained from room temperatureto -50°C.
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GoddardSpaceFlightCenterpersonnelhavedevelopedthe JPL suggestion
into hardwareusingcomputeranalysistechniquesdevelopedfor such
applicationsas ensuringthe thermalbalancein spacecraft.The completed
freezingsystemhas been testedat the NationalCancerInstituteand at
the JohnsHopkinsUniversityMedicalCenterin Baltimore. The successful
test resultshave beendocumentedin threejournalpublications.
A manufacturerhas showninterestin commercializingthe freezing
unit,but the unitrequiressomeredesignto make it more reliableand
convenientto use. He has submitteda proposalto redesignand to
marketthe system. Dr. Scearceand Dr. Clingmanare workingwith Don
Friedman,TechnologyUtilizationOfficerof GoddardSpaceFlightCenter,
to evaluatethis opportunity.
In a separatecom_nercializationproject,JPL has enteredintoa
contractwith a largecommercialorganizationto developa commercial
systemfor preservingred cells. JPL has completedand testeda
sophisticatedfreezingsystem. JPL'sprogresspleasedthe corporation,
but its new productdevelopmentfundswere depleted. ThusJPL terminated
its developmentand testingprogram. When additionaldevelopmentfunds
are available,the commercialorganizationwill reconsiderthis project.
The teamwill: (1)continueto monitorthissituation,(2)provide
assistanceas appropriate,and (3) insurethat no conflictexistsbetween
Goddardand JPL commercializationprojects.
FemaleIncontinence
BATeamPersonnel: Ms. DorisRouse
One of the techniques for the management of urinary incontinencein
males involves the use of an external roll-on rubber cuff and a col-
lection bag attached to the leg. This closed collectionsystem overcomes
many social and health problems resultingfrom exposure of the urine to
the air and the skin. A successfulclosed collectionsystem for females
is not available. Urine incontinencein females, therefore,must be
managed by diapers and pads or by catheterization.
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The RTI team is workingwith JohnsonSpaceCenterin the develop-
ment and evaluationof a femaleurineincontinencecollectionapparatus
(FEMUICA).The objectiveof the programis to developan externalurine
collectiondevicethatis leakproof,comfortable,and simpleto apply,
remove,and keepclean. The followingmodificationshavebeenmade to
the originaldesign: (1) the positioningpessaryhas been eliminated
and replacedwith a flexiblevaginalseal,and (2) a pantysupport
systemhas been addedto maintainthe devicein position.
An initialconfiguration,fit,and functiondemonstrationhas been
completedon a healthyvolunteersubject. The subjectwas able to wear
the devicefor 12 hoursas specifiedby the protocolwith no discomfort.
A managementadvisorypanelconsistingof urologistsas well as NASA
physiciansand engineerswill meet in Januaryto reviewtheseinitial
test resultsand to designthe protocolfor the next evaluation.The
RTI teamwill participatein thissession.
The FEMUICAhas a promisingcommercializationpotential. Two
majormanufacturersof devicesfor managementof incontinencehave
expressedan interestin marketingthe FEMUICA. A representativefrom
one companyvisitedJohnsonSpaceCenterin August1978. Dr. W. H.
Clingmanhas arrangedfor representativesfromthe othermanufacturerto
discussthe projectat JSC in lateJanuary.
GaitAnalysisData Bank
BATeamPersonnel: Dr. RichardScearce
Technologyadvanceshavemade gaitanalysisa more usefulanalytical
tool for rehabilitation.Computersrapidlyanalyzelargequantitiesof
data that have beengatheredusingelectromyographicelectrodes,force
plates,and motionpicturecameras. Graphicdisplayspresentthe in-
tegrateddata in a formatthat allowsdetailedstudyand analysisof the
patient'sgait. Althoughthesetechniquesare available,physiciansand
therapistsseldomuse them becausemuchmore dataare availablethan can
be assimilatedin a reasonabletime period. Thus researchersmust
devisemeansto extract,fromthe voluminousdata,parametersthat
correlatewellwith specificdiagnoses.
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The problemoriginator,Dr. SheldonSimon,has an extremely
advancedgait analysislaboratorywhichhe usesas a clinicaltool.
Recordsfrom each gait analysisperformedin this laboratoryare
compiledinto a gait analysisdata bank. Fromthisgrowingvolumeof
data,the clinicianmust identifythe parametersthatcorrelatewith
diseasestates. Dr. Simonhas askedwhetherNASAhas technology,in the
form of data processing,analysis,and storagetechniques,applicableto
his research.
The team has enlistedthe talentsof Dr. C. FrankStarmer,of Duke
University,to assistDr. Simonwith his computerizedata bankmanage-
ment. Duringa summerfellowshipat Jet PropulsionLaboratory,Dr.
Starmermasteredmanyof NASA'simage-processingtechniquesand used
them to developthe Duke CardiovascularData Bank. Dr. Starmerand Dr.
Simondiscussedthe gaitanalysisdatamanagementproblemand agreed
that NASA technologyappearedapplicable.
Dr. SimonvisitedDr. Starmerin Novemberand inspectedthe Duke
CardiovascularData Bank. He foundthe computerhardwareand software
compatiblewith his computersystem,but he also foundthatthe software
wouldrequiresomerewritingto be directlyapplicableto his needs.
Fortunately,anotheruniversitycurrentlyis rewritingmuch of this
softwareas partof an effortto installthe DukeCardiovascularData
Bank in its hospital. The rewritewill be completedin 6 months. Dr.
Starmerplansto giveDr. Simona copy of the new softwareto adaptto
his needs. The problemoriginatorestimatesthissoftwarepackagewill
save him yearsof developmenteffort.
High-SpeedDC Log Amplifier
BATeamPersonnel: Dr. ClarkBeall
Logarithmicprocessingof transducersignalsis a uniquedata
compressiontechniquethat greatlyamplifiesthe smalleramplitude
signalswhileattenuatinglargerones. At the presenttime,several
typesof electronicfunctionmodulesare availablecommercially,which
convertAC analogsignalsto voltagelevelsproportionalto the logarithm
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of the inputvoltagelevel. However,the logarithmiconversionof DC
signalsis a more difficultproblembecausethe frequencyresponseof
the logarithmiconverterfallsoff as an inversefunctionof the DC
signalamplitude.
. A medicalresearcherhas requestedNASA assistancein identifyinga
logarithmicircuitthatcouldprocesshigh-frequencylow-current
signals,suchas thosedetectedin experimentswith artificialmem-
branes.
A searchof NASA literaturehas locateda contractor eport
(vol.l, contractNAS5-22577)whichcontainsa descriptionof a DC log
amplifierthatseemsto fulfillthe requirementsof the originalproblem
statement.This patentedcircuitwill be evaluatedin the near future
and shouldfind acceptancein themarketplacebecauselog amplifiersare
utilizedin many areasof thechemicaland physicalsciences,research,
and industry.
HorizontalShower
BATeamPersonnel: Dr. ClarkBeall
The National Instituteof Aging has funded a project for Research
Triangle Instituteand Dorothea Dix Hospital to identifymeans of
improvinghealth care for elderly bedriddenpatients. The NASA hori-
zontal shower has been identifiedas an item of technologythat has
promise for safer and more convenient bathing of these patients.
Two models of the horizontalshower are ready for shipment from the
NASA Ames Research Center. These showerswere built from original NASA
blueprints in response to a request from the RTI team to the Ames
Technology UtilizationOffice.
As soon as bailment papers can be prepared,the shower units will
be shipped to Dorothea Dix Hospital. There they will be evaluated for
efficacy by a protocolexaminationof a variety of parameters.
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HydrocephalusShunt
BATeamPersonnel: Dr. RichardScearce
Hydrocephalusis a conditionof abnormalenlargementof the cere-
bral ventriclesresultingfrom a rise in pressureof the cerebrospinal
fluid.To relievethis pressure,surgeonsimplanta shuntto drainthe
excesscerebrospinalfluidintoothercavitiesof the body. These
shuntsfrequentlyfailbecauseof inletblockageof the device's
ventricularcatheter. The inletis blockedby an ingrowthof choroid
plexus,or the accumulationof cellularor fibrindebris. Mr. BruceA.
Banksof LewisResearchCenterhas proposeda catheterinletdesignto
minimizethisblockage. He proposesa multiendedinletcatheter,with
hundredsof tiny inletsformedby ion-etchingtechniques.Thisdesign
has theseadvantages:(1)the hole'ssmalldiameterinhibitstissue
ingrowth,and (2) the multiplicityof holeslimitsthe possibilityof
blockage.
The teamworkedcloselywith Mr. Banksand SandyF. Felderof Lewis
ResearchCenterto evaluatethe proposal,reviewthe medicalliterature,
and visitthe problemoriginator.As a resultof the team'sdiscussions
concerningthe projectwith individualswithinthe NationalInstitutes
of Health,Dr. Ayub K. Ommayaof the NationalInstituteof Neurological
CommunicativeDisordersand Strokewill forwarda writtenstatementof
his supportof the designto Ray Whittenof NASAheadquarters.Cur-
rently,the team is assistingMr. Banksin arranginga pre-engineering
designmeetingbetweenthe potentialmanufacturer,severalneurosurgeons
(includingthe problemoriginator)and NASA-Lewispersonnelto discuss
the proposeddesign. A writtensummarystatementfromeach attendee
will be submittedto Mr. Whittenfor his considerationin evaluatingthe
project.
ImprovedOptics for VitrectomySurgery
BATeam Personnel: Ms. Doris Rouse
Visualizationof the retina is an importantdiagnostic procedure in -
ophthalmology. Reflectionsfrom the eye lens or a clouded vitreous,
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especiallyin olderpatients,can seriouslyimpairthe resolutionof the
imageseen by the physician.
In responseto the RTI team descriptionof thisproblem,Don
Bucheleat LewisResearchCenterhas constructedan opticalscanning
systemthatminimizesthe effectsof lightscatteringand improves
- resolution. Dr. Oleg Pomerantzeff,the problemoriginator,visited
LewisResearchCenterwith Ms. Rousein July 1978for a demonstationand
was enthusiasticaboutMr. Buchele'ssystem.
Ms. RousevisitedLewisResearchCenterin Octoberwith a repre-
sentativefrom an ophthalmologyinstrumentationmanufacturerto discuss
the scanningsystem. This companyis currentlyevaluatingthe efficacy
and marketpotentialof the device. Mr. Buchelehas prepareda patent
disclosureand journalmanuscript.
InvestmentCastingof ChromiumAlloys
BATeamPersonnel: Dr. ClarkBeall
Chromiumalloysseemto be attractivealternativesto gold in the
fabricationof dentalfixtures. Thesealloysare 50 to 70 percent
chromium,with the remaindereithernickelor cobalt.
Duringfabrication,themoltenchromiumalloyis cast in a ceramic
mold thathas beenmade from an impressionmodelof the patient's
mouth. The problemencounteredin this "investmentcasting"processis
that the moltenmetalinteractswith the ceramicsurfaceof the mold to
producedefectivesurfaceson the castings.
A comprehensivesearchof NASA literatureon investmentcasting
techniqueshas beenconcluded. The researcherhas requestedcopiesof
many documentslistedin the searchabstract.
BillWaters,of the LewisTechnologyUtilizationOffice,has
respondedto the originalproblemstatement.Mr. Watershas an ex-
tensivebackgroundin metallurgyand metalfabricationand has volun-
teeredto assistthe dentalresearcherin the applicationof NASA
investmentcastingtechnology.
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MicroliterFluidDeliverySystem
BATeamPersonnel: Dr. ClarkBeall
Severaltypesof fluidpump systemshave been identified uring
recentsearchesof NASA literature.One typeof pumpseemsuseful
for deliveryof fluidin the microliterrange. Anothertypeof pump
is capableof deliveryof fluidin the fractionalmillilitervolume
up to lO millilitersper minute.
An engineerat NASA LewisResearchCenterhas proposeda gas-driven
pumpwhichusesan electrochemicalmeansto generateknownvolumesof
gas which,in turn,movesthe volumeof fluid. Dr. Clingman,com-
mercializationconsultant o the RTI team,is evaluatingthe commercial
potentialof this pump.
Anothertype of gas-drivenpumphas been identifiedin Tech Brief
MSC-14905.This pumpuses CO2 gas froma cartridgeto powera small
bellowssystem. The bellowsproducesa constantforcewhichexpresses
fluidfrom a bladderat a constantpreadjustablerate. The performance
data for this pumpare presentedin the supportpackagefor the Tech
Brief. Usableflow ratesvaryfrom 6 ml/minuteto lO0ml/minute.
About+ 5 percentaccuracyis maintained.Improvementof low flow-
rate performanceof the pumpby the incorporationof a feedbackcontrol
is beinginvestigated.This typeof pumpwouldbe usefulas a bedside
infusionpumpwhichcouldmaintainlong-termaccuracyof flow.
MicrowaveThermography
BATeamPersonnel: Dr. ClarkBeall
Microwavethermographytheoreticallycan measuretemperaturegradients
in the humanbody to O.l K. Therefore,the techniquehas application
potentialin severalareasof medicalresearch. A proposalfor a bio-
medicalevaluationof NASAmicrowavethermographyhas been preparedby
DukeUniversityNeurologyDepartmentresearchersat the requestof the
TechnologyUtilizationOfficeof GoddardSpaceFlightCenter.
An essentialitemof instrumentationfor this researchis an
expensivedeviceknownas a microwaveradiometer.The researchproject
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was unable to proceed at first because all the NASAradiometers at
Goddard were in use. However, the medical researchers located another
source for acquiring a radiometer on loan.
The project plan is to conduct a brief survey study to determine
the potential for microwave thermography in neurological applications.
Once several specific applications have been identified, requests for
National Institutes of Health funding will be prepared.
To facilitate this survey study, the Goddard Technology Utilization
Office has funded a grant of $5,000 to the researchers. These funds
will be used for the immediate purchase of required laboratory materials.
Neonate Thermal Control Garment
BATeamPersonnel: Ms. Doris Rouse
A newborn child's inability to compensate for body heat loss in the
operating room can lead to serious metabolic and respiratory difficulties.
As a result, surgery is especially hazardous in the first 4 weeks of
life. Efforts to solve this problem include the use of heated operating
tables, elevated room temperature and infrared radiation sources. Each
method has an undesirable side effect such as hot spots on the infant,
unacceptable working conditions for the surgical team, or uneven heating
of the infant. A modification of the astronaut liquid-cooled space
suit design has been applied to this problem.
NASA's Ames Research Center built an infant thermal control suit
incorporating a series of parallel, closely spaced flow channels that
are supplied with water from an external water bath and pump. A wrap-
around, form-fitting modular design with Velcro fasteners is used to
provide easy surgical access to various body areas of the infant.
f
Dr. J. N. Brown participated in a thermal control system com-
mercialization meeting at Ames Research Center on March 14, 1978.
Other participants included representatives of NASA, a medical devices
manufacturing and distributing company, and the Stanford Bateam. The
participants discussed the broad spectrum of medical applications of NASA
technology and the present state of the art of that technology. Ongoing
demonstration programs involving the thermal control systems were described.
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The manufacturer'srepresentativeindicateda specificinterestin
possiblecommercializationof a neonatethermalcontrolsystemthat
wouldbe applicableduringneonatesurgeryand in neonatetemperature
controlin general. ThreecompanyrepresentativesvisitedRTI and North
CarolinaMemorialHospitalin May 1978to discussthe marketpotential
for the neonategarment. A firmcommitmentto developa productfrom
thisNASA technology,however,was deferredpendingdocumentationof the
garment'sefficacyin surgeryby Dr. ErnestKraybill,the problem
originator. Effortsto repaira defectivewater-bathand pumpingunit
have delayedthisclinicalevaluationfor severalmonths. Followingan
extensiveevaluationof theunit by the RTI ElectricalSafetyLaboratory,
AmesResearchCenterwill sendDr. Kraybilla new unit for use in his
surgicalevaluations.
NeuroelectricControl
BATeamPersonnel: Dr. RichardScearce
Poweredprosthesesusuallyuse myoelectricsignalsto control
movementsof the artificiallimb. Sincethe availablemyoelectric
signalsoftenare not relatedto the desiredmovement,thiscontrol
techniqueis not entirelysatisfactory.The amputeeusuallymust
focushis entireattentionto supervisemovementof the prosthesis.
The problemoriginator,Dr. CarloDeLuca,has proposedan alternate
approachconsistingof a neuroelectricontrolsystem. He proposesto
detect,withinthe amputee'sstump,the electricalsignalsbeingtrans-
mittedalongseveralpertinentnervesand to use thesesignalsto control
an upperlimb prosthesis.Specialelectrodeswoulddetectthe neuro-
electricsignal. A miniaturizedimplantedtelemetrydevicewould
amplifythe signaland transmitit to the prosthesis.The implanted
systemcouldbe externallypoweredviaan RF inductancecoupling.
Dr. DeLucaand his colleaguesdevelopeda successfulrecording
electrode,whichwas implantedin rabbits. The electrodesuccessfully
detectedthe motorcontrolsignalsthroughoutlong periodsof implan-
tation. Autopsyindicatedthatthe nervestoleratedtheelectrode.
Dr. DeLuca'sgroupnowmust developthe implantablelectronicsto
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processand transmitthe controlsignal. He askedif NASA has tech-
nologyor experiencein the developmentof reliableminiaturized
electronicsthat couldbe appliedto thisproblem.
The team discussedthe needwith Dr. DougO'Handleyof Jet Pro-
pulsionLaboratory(JPL). They agreedthatJPL has the capabilityand
. experience,especiallyin the areasof miniaturizedimplantable,bio-
compatibletelemetrysystems. The teamforwardedcopiesof Dr. DeLuca's
publicationwhichdescribedthe neuroelectricontrol,with the
designspecificationsof the proposedelectronicsto Dr. O'Handley.
Dr. JohnW. Wojnaroskiof JPL contactedDr. DeLucaand discussed
establishmentof a collaborativeffort. Dr. Wojnaroskiplansto visit
Dr. DeLucain January1979.
NeuropathicTester
BATeamPersonnel: Dr. RichardScearce
The problemoriginatordescribedthe need for an improvedmethodof
diagnosingand evaluatingthe therapyfor severaldisorders,including
Parkinson'sdisease. In responseto theseneeds,LangleyResearchCenter
engineeringpersonneldevelopedthe neuropathictester. The problem
originatorevaluatedthe deviceand was pleasedwith its performance.
The team identifieda manufacturerinterestedin marketingthe
neuropathictester. The commercialversioninitiallywouldbe sold as a
researchtool,but its eventualmarketwouldbe primarilyas a diagnostic
device. Beforecommercialization,however,two majorproblemsmust be
solved: (1)how to pay for the clinicaltrials,and (2) how to redesign
the deviceso it couldbemarketedat an acceptableprice.
The solutionto the firstproblemwas quicklyfound. In Marchand
June 1978,a teammembervisitedDr. DonaldB. Calneof the National
Instituteof NeurologicalCommunicativeDiseaseand Stroke. Dr. Calne
agreedto performthe clinicalevaluationat no cost to NASA,if he was
provideda commercialversionof the tester. Thisarrangementwas
acceptableto themanufacturer.
The secondproblemhas provedmore difficult.The team has shipped
the neuropathictesterto themanufacturer,wherethe engineeringstaff
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is attemptingto redesignit. The teamalso contactedan independent
engineeringfirm,whichagreedto studythe deviceand submita proposal
to LangleyResearchCenterfor the redesigntask.
New Methodfor CleaningTeeth
BATeamPersonnel: Dr. RichardScearce
Dr. Joseph Heyman of Langley Research Center proposeda new method
for cleaning teeth that would couple very low-levelultrasound into a
water jet. An abrasive material such as diatomaceousearth would be
suspended in the water. Powered by ultrasoundenergy, the suspended
abrasive material would clean the teeth.
In August 1978, Dr. Heyman submitteda patent application for this
device. In a meeting with an RTI team member, individualsfrom the
National Instituteof Dental Research verified the need for an improved
cleaning technique,but indicatedthat they could not become involved
until the feasibilityof the concept had been demonstrated. Thus the
team is working with Dr. Heyman and John Samos, the TechnologyUtilization
Officer of Langley Research Center, to develop a functionalprototype.
In January 1979, Dr. Heyman will begin fabricationof the prototype.
PortableCoolingSystemfor Quadriplegics
BATeamPersonnel: Ms. DorisRouse
One consequenceof the quadriplegiacaused by cervical spinal lesions
\ is vulnerabilityto heat stress resultingfrom the inabilityto perspire
belowthe level of injury. This condition is due to the interruptionof
autonomic neural pathways that mediate thermoregulatorysweating and
vasomotion. Quadriplegicsexposed to even moderately high temperatures
risk hyperventilation,increasedheart rate, and heat stroke. A portable
cooling garmentwould eliminate this risk, thus opening new employment
and daily living opportunitiesfor individualspreviouslyconfined to a
temperature-controlledenvironment.
Ames Research Center responded immediatelyto the RTI team's problem
statement. A contract for fabricationof a prototypecooling vest has been
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awarded. Engineersat Ames are designinga small,lightweightwater
coolingand pumpingsystemfor the unit. Designparametersfor the vest
and the pumpingunitwere derivedfromconversationswith quadriplegics
who willparticipatein the earlyevaluationof the system. This study
is scheduledto beginin March1979.
PoweredRim ControlWheelchair
BATeamPersonnel: Dr. RichardScearce
A two-axisjoystickis themechanismcommonlyusedto control
poweredwheelchairs.However,elderlypersonsand personswithmuscular
deficienciesoftenlack the necessaryskilland reactiontime to operate
thiscontrolsafely. They may be capableof operatingnonpoweredwheel-
chairswith the hand-rimcontrol,but they tirequickly. _hus these
individualsare confinedto theirhomes. With a poweredwheelchairthat
uses a modifiedhand-rimcontrolsystem,theywouldregainmuch of
theirlostmobilityand independence.
The AppliedPhysicsLaboratoryof JohnsHopkinsUniversitydesigned
and builta demonstrationwheelchairwith a poweredrim control. The
test resultshavebeen encouraging,but more engineeringdevelopmentis
needed. The APL engineersplanto utilizeNASA technologyin the re-
designeffort.
Dr. JulesTaylorof GoddardSpaceFlightCenterrequestedassistance
from the team in planninga jointprojecton thiswheelchairinvolving
NASA,the NationalInstituteon Aging,and JohnsHopkinsUniversity.
The team is currentlyworkingwith theseorganizationsto coordinatethe
cooperativeffort.
PressureTransducerCalibrator
BATeamPersonnel: Dr. RichardScearce
The devicewas evaluatedby a cardiologist,a majormanufacturer
of pressuretransducers,and Dr. WilliamH. Clingman. Theirinitial
testsindicatedthat the devicehad to be modifiedto acceptthemanu-
facturer'stransducersand to permitthe introductionof a sterile
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catheterinto the pressurechamber. Thesemodificationshave beenmade.
Testingwill resumein January1979.
Proper Technology for Cold Formin 9 Titanium Alloys
BATeamPersonnel: Dr. Clark Beall
Titaniumalloyshave beenrecentlyintroducedintodentistryfor the
manufactureof prosthesesof the humanjaw. A finalfit of the prosthesis
to the patientinvolvesthe surgeon'sadjustingand bendingthemetal
with varioustypesof pliers. This "coldforming"seemsto introduce
hairlinefracturesin the metal,resultingin the failureof a significant
numberof thesetitaniumprostheses. A brokenprosthesismust be
replacedby anothersurgicaloperation.
DentalresearchershaverequestedNASA assistancein solvingthe
problemsintroducedby cold formingtitaniummetal. A comprehensive
literaturesearchhas beenconcluded,and the researcherhas requested
copiesof many documentslistedin the surveyabstract.
Bill Waters,of the LewisTechnologyUtilizationOffice,has
volunteeredto assistthe dentalresearcherwith NASAmetallurgical
technology.Mr. Watershas extensiveexperiencein metallurgyand
metalfabrication.
ProstheticUrinarySphincter
BATeamPersonnel: Ms. DorisRouse
Urinaryincontinencemay resultfromcongenital,traumatic,post-
surgical,or neurogenicdisorders. A malfunctioningurethralsphincter
is oftenresponsiblefor this inabilityto controlvoiding. In these
cases,continencecan be restoredby an implanted evicethat occludes
the urethraand allowsvoluntaryvoidingby themanualreleaseof the
occludingpressure. Whileresultswith currentlyavailabledevicesare
encouragingfromthe standpointof restoringurinarycontinence,two
factorspreventwidespreadacceptanceof thesesphinctersystemsby the
medicalcommunity: (1)surgicalcomplexityof the implantation
procedure,and (2) the high rateof devicemalfunction,oftena result
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of valvefailure. The availabilityof a simpler,more reliablesystem,
therefore,wouldrepresenta significantadvancein the managementof
urinaryincontinence.
In responseto a problemstatementby the team,Ray Helmsand
HaroldSmylyof MarshallSpaceFlightCenterdesigneda prosthetic
sphinctersystem. The two primaryadvantagesof thisdesignare
minimumsurgeryfor implantationand improvedminiaturizedvalvesfor
maximumreliability.The valveincorporatesdesigncharacteristics
developedby NASAto obtain"zero"-leakagehigh-reliabilityvalvesfor
rocketsystems.
Medicaldevicemanufacturerswere askedto submitproposalsto
MarshallSpaceFlightCenterfor the fabricationand testingof a pros-
theticurinarysphincterincorporatingthe NASA valvesystem. Three
• proposalswere receivedfromorganizationsexperiencedin the designand
assemblyof prostheticdevices. The proposalswere reviewedby a panel
consistingof the team,MarshallSpaceFlightCenterand NASAHeadquarters
personnel and urologists,and a representativefromthe NationalInstitute
on Aging• The contractwas awardedto RochesterGeneralHospitalin
July 1978. Valvesfor the prototypesystemsare currentlybeing
fabricated.Animalimplantstudiesare scheduledto beginin July 1979.
Commencementof clinicaltrialsis plannedfor July 1980. Severalmedical
devicemanufacturershave alreadyexpressedan interestin marketingthe
NASA sphinctersystem.
SimplePresettableTorqueBrakeSystem
BATeamPersonnel: Dr. ClarkBeall
The RTI team has respondedto an inquiryfrom a manufacturerof
low-costexercisemachinesfor a torquebrakethatwouldbe easy to set
to varioustorquesyet couldbe resetexactlyto any giventorque
value. With sucha presettabletorquebrake,many peoplecoulduse the
exercisemachinewithina day by simplysettingthe torquebraketo the
levelprescribedfor them by theirphysicians.
A proposedsolutiontothis problemis in the handsof the
manufacturer.The manufacturerhas fabricatedseveralexercisemachines
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incorporatingthe proposedtorquebrake. Thesemodelsare being
evaluatedin severalmedicalcentersby themanufacturer.Preliminary
feedbackto the RTI team is favorable.The RTI team is awaitingthe
manufacturer'sdecisionto beginlarge-scaleproductionof the exercise
machine.
TeletypeTest Set
BATeamPersonnel: Dr. ClarkBeall
The teletype (TTY) test set was designed to perform field main-
tenance and repair the typical home teletype installationused by the
deaf for phone communications. Prototypemodels of the teletype test
set have proved to be useful devices in field tests by teletype repair-
men. Engineersat GallaudetCollege have evaluated the device and plan
to make several units for their own use in the maintenanceof teletype
sets on campus.
The present RTI team efforts concentrateon identifyinga suitable
manufacturer for the TTY test set. A team member's visit to the office
of Eugene Rosen, of the NASA Small BusinessAdvisor Office, resulted in
the identificationof severalminority businessescapable of manu-
facturing the teletype test set. Contactswith these manufacturershave
been initiated.
TissueViabilitx
BATeamPersonnel: Dr. ClarkBeall
This problem has emphasizeddevising a means of sensingand measuring
the viability of human body tissue by some remotemeans. The optical
measurementof infrared absorbencechanges in cellular cytochromes is a
promisingtechnique that would assay the intrinsicoxygenationof bio-
logical tissues. The difficulty lies in developingan instrumental
protocol for this optical test.
Engineersat Marshall Space Flight Center have decided that re-
flectance spectroscopyis not sensitiveenough to serve as the analysis
technique and have suggested internalreflectionspectroscopybe used.
This technology is being investigated.
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Figure 8. Teletype Machine Test Unit Prototype.
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TTY Keyboard Tester
BATeamPersonnel: Dr. Clark Beall
..
The TTY keyboard tester is a companion device to the TTY test set.
Both devices are intended for use by repairmen who must service Baudot
Teletypes in the homes of the deaf who use the teletypes for telephone
communication. Preliminary designs have been formulated for the TTY
keyboard tester by the NASAengineer at Langley Research Center who
developed the TTY test set. The actual prototype development of the
keyboard tester awaits the successful commercialization of the TTY test
set.
Weight Alleviation Device
BATeamPersonnel: Dr. Richard Scearce
An evaluation of the weight alleviation device at the Mississippi
Methodist Rehabilitation Center demonstrated that this NASA-developed
system could significantly reduce the time required for training the
severely handicapped to transfer into and out of a wheelchair. This
training, called transfer training, normally must be delayed until the
patient has regained his strength. With this device, transfer training
and strength-building therapy may be done concurrently, thus reducing
the hospital stay as much as 3 weeks.
The weight alleviation device was redesigned to meet the marketing
requirements for a less expensive device. In December 1978 this lower
cost version was delivered to the Mississippi Methodist Rehabilitation
Center for a l-month evaluation. With favorable test results, a manu-
- facturer has agreed to fabricate a commercial model. Clinical trials
then will be initiated at other rehabilitation centers.
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6.0 INACTIVATEDPROJECTS
During the reporting period, I0 projects were removed from the
team's active list. A successful NASAtechnology transfer was not antici-
pated in these projects as a result of inadequate mission agency support,
or absence of a unique NASAsolution, or the identification of a satis-
factory non-NASAsolution. These projects and the rationale for their
inactivation are presented below.
Advanced RuggedHearing Aid for Children
BATeamPersonnel: Mr. Robert Beadles
In 1977 the Bureau of Education for the Handicapped approached NASA
Headquarters concerning the need for a child's hearing aid capable of
withstanding substantial vibration, shock, and occasional immersion in
water. Currently available hearing aids, especially the devices designed
for children, have unacceptable failure rates. The team prepared a
problem statement for NASAHeadquarters to distribute to the field
centers. Several promising proposals were received. At this time,
however, other committments forced the Bureau of Education for the Handi-
capped to withdraw co-funding support from the project. Further action
has been delayed, therefore, pending the identification of another
i'
supportive mission agency.
A Tool for Rapidly Fusing Surgical Suture Knots
BATeamPersonnel: Dr. Clark Beall
Ultrasonic melting devices are used in the plastics fabrication
industry for forming spotwelds and seams in plastic sheeting. A small-
scale device of this type would probably be a good solution to the
problem of fusing surgical suture knots. A more promising NASAtechnology
was not identified.
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ElectromagneticFlowmeterCalibrator
BATeam Personnel: Dr. Richard Scearce
The team investigatedseveralsuggestedsolutions,but noneof the
ideaswere suitable. No othersolutionswere identifiedand, therefore,
the teamclosedthis problemin February1978.
InertMaterialfor InsertionintoCranialBurr Hole
BATeamPersonnel: Dr. ClarkBeall
The searchfor a machinable,durable,X-raypermeablematerial
(foruse as a tap for cranialburr holes)has concludedin a non-NASA
solution. The materialthatshowsthe most promiseis the Corning
machinableceramic. Thismaterialis commerciallyavailableand is
beingevaluatedfor thisapplicationby themedicalresearcher.
InfraredTwo-DimensionalImaging
BATeamPersonnel: Dr. ClarkBeall
The original problem statementdescribed an applicationthat has
since proven untenabledue to the very low light intensityavailable
for imaging. The concept of an infrared light probe of living tissue
is a viable concept, however. This concept is being consideredas
part of the solution to the RTI team problementitled "TissueViability."
Sealin9 of .AmputationStum2 Neuromas to Prevent Pain
BATeam Personnel: Ms. Doris Rouse
The end of a severed nerve often develops a bulb or swelling
called a neuromawhich is hypersensitiveto pressure or traction. A
neuroma representsa distorted portionof the injurednerve in which
regeneratingaxons have escaped the normal perineurialbarrier to grow
in a disorderly fashion. Neuromaswhich form in amputation stumps are
particularlypainful because they occupy an unprotectedposition at the
new extremitywhere they are subject to repeated blows, pressure and
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irritation.The amputeeis oftenincapacitatedby severepain,and, in
thesecases,the constantneed for painkillingdrugscan leadto drug
addiction.
A thoroughsearchof the medicalliteraturerevealedthat the
numeroustechniquesemployedto relievethe neuromapain had all been
unsuccessful.The possibilityof sealingthe severednerveto prevent
neuromaformation,however,appearedto be themost promisingsolution.
Attemptsto cap the nervewith silasticwere unsuccessfuldue to the
inabilityof preformedcaps to forman effectivesealof the nerve.
An adhesivematerial,ratherthana preformedcap, was neededto form
a sufficientseal. Neitherthematerialnor themethodof application
shouldinjurethe nerve.
Responseto the problemstatementfrom the NASA fieldcenters
indicatedthat no uniqueNASAtechnologywas applicableto the solution
of the problem. Namesof individualsto contactin the polymerindustry,
however,were providedby chemistsat LangleyResearchCenter.
In a reviewof the medicalliterature,a paperin a conference
entitled"Kunstoffein der Chirurgie"was found. The paperdiscussed
the use of cyano-acrylatesin peripheralnerverepair. The adhesives
foundunsuitablefor nerverepairdue to theirinhibitionof nerve
growthmay be quiteusefulin preventingneuromaformationat a severed
nerveending. The paperwas translatedfromGermanby DorisRouseand
forwardedto the problemoriginatorwho is currentlytestingthese
compoundswith animals.
The problemand the resultsof the literaturesearchwere presented
to the SurgicalProductsDivisionof an adhesivemanufacturingcorporation.
They were very positivein theirresponseand are currentlyworkingwith
the problemoriginator.
Althougha NASAsolutionfor thismedicalneedwas not available,
the activitiesof the teamdid providethe basisfor an industry/clinician
researcheffortthatmay resultin a new surgicaltreatmentof wide impact.
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Upgrading of Performance of the Tracheal Stethoscope for
Reliable Respiration and Heart Rate Monitoring During Surgery
BATeamPersonnel: Dr, Clark Beall
Several companies are now marketing esophageal monitoring probes
for the measurement of either electrocardiogram, or heart and lung sounds,
or core body temperature. No unique NASAtechnology was ever identified
for combining several of these medical parameters into a single probe.
UV Dosimeter/Sunburn Monitor
BATeamPersonnel: Dr. Clark Beall
This problem failed to receive RTOPfunding due to the lack of
cofunding. Cofunding for research and development is not anticipated
in the next year.
Vaginal Mucosal Blood Flow
BATeamPersonnel: Dr. Richard Scearce
The problem originator has developed his own solution to this
problem. Since the solution is adequate and NASAtechnology is not
needed, this problem is closed.
V-Slotted Head Screws
BATeamPersonnel: Dr. Richard Scearce
The objective of this project was to evaluate the use of V-slotted
head screws in prostheses and orthoses. The team obtained the screws
and special screwdrivers necessary for the problem originator to
fabricate several braces. Faulty screwdrivers, however, invalidated
the initial evaluation. Before another test could be arranged by the
i team, the problem originator died. The project was closed pending
I the identification of another innovative, aggressive investigator. '_
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7.0 TECH BRIEFSTUDY
During1978the RTI teamconductedan informalstudyof the NASA
Tech Briefpublicationsto evaluatethe potentialof the Tech Briefsas
a sourceof ideasformarketablebiomedicalproducts. The studywas
basedupon the hypothesisthatmarketableproductsmay be derivedmore
easilyfromthoseitemsof NASA technologythat generatedthemost
inquiriesfor Tech BriefTechnicalSupportPackages.
Procedure
Two individualswho were familiarwith the NASA technologytransfer
proceduresurveyeda representativesampleof NASATech Briefspublished
during1970-1975and selectedthosetitlesthatseemedlikelycandidates
for biomedicalapplications.The titlesthenwerematchedagainsta
listingof the "mostpopular"Tech Briefsof thisperiod. Douglas
Johnson,of DenverResearchInstitute,suppliedthe RTI teamwith a
listof the "lOmost popular"Tech Briefsin eachof the nine categories
intowhichTech Briefswere segregated uringthe period1970-1975.The
DenverResearchInstitute'scomputeralso provideda listingof approxi-
mately40 randomlyselectedTech Briefsin each of the ninecategories.
Copiesweremade of all 502 Tech Briefs,and the copieswere stackedby
NASA serialnumberdesignation.TheseTechBriefswere evaluatedby
Dr. ClarkBeall,of the RTI NASA BATeam,and Dr. Theo Pilkington,chairman
of the DukeUniversityBiomedicalEngineeringDepartment.The purpose
of the evaluationwas to selectthoseTech Briefsthat seemedto have
potentialutilityin biomedicalproductdevelopment.A shortparagraph
was requestedto describethe more obscureapplicationideas.
Results
Table 6 is the breakdownof the Tech Briefs selected in the evalua-
tion. Note that the "random" listing from the Denver Research Institute
contained 14 Tech Briefs that had already been listed on the "lO most
popular" list.
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Table6. Breakdownof Tech BriefsSelectedfor Evaluation
Tech Classi- Random "MostPopular" Duplicates TotalTech
fication Listing Listing (bothlists) Briefsin
Study
l 61 + II 2 = 70
2 56 + II l = 66
3 69 + lO l = 78
4 66 + II l = 76
5 27 + lO l = 36
6 42 + lO 5 = 47
7 37 + 9 l = 45
8 23 + 9 2 = 30
9 44 + lO 0 = 54
42_ 9-I- _ 50---2
Table7 givesthe raw data from the evaluationof the Tech Brief
selection.Note that aboutone-thirdof the selectedtitleswere from
the Life Sciencescategory,so the applicationspotentialof thesewas
obvious. Thoseselectionsnot from the Life Sciencescategorywere set
asidefor furtherstudy.
Table7 showsthatDrs. Bealland Pilkingtonselectedaboutone each
of the "lO most popular"Tech Briefsin each of the nineTech Brief
categories.The tablealso showsthe relativenumbersof all NASA Tech
Briefsfallingwithinthe ninecategoriesduringthe period1970-1975.
Of all the titlesthatwere selectedby the evaluationas showing
promisefor biomedicalapplications,only six titleswere selectedby
both persons. Table8 liststhe titlesof theseTech Briefs. Threeof
thesesix titleswere fromthe "lO most popular"listingof Tech Briefs.
Thesethreeitemsdeservespecialattention:
I. One describesa devicethat is now commerciallyavailable
(70-I0282),
2. One describesa devicevery similarto the subjectof a current
RTI BATeamproblemstatement(70-I0508),and
3. One is a computerprogramfromMarshallSpaceFlightCenter
(72-10614)and can be obtainedthroughthe COSMICfacility.
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Table7. Tech BriefSelection
Theo Pilkington ClarkBeall
Tech Brief• Random "MostPopular". Random "MostPopular"
Category List List List List
I. Electronics 7 2 9 l
2. Electric 8 2 7 l
Systems
3. Physical 7 l 7 l
Science
4. Materials 3 l 2 l
Chemistry
5. LifeSciences 19 l 7 3
6. Mechanics 0 l 2 l
7. Machinery, l 0 l 0
Tools,etc.
8. Fabrication 0 l 0 0
Technology
9. Computer 3 l 2 l
Programs
_-_ TO- 3--% -9
Table8. Titlesof Tech BriefsChosenin Con_non
Number Titles
70-I0096 SignalConditionfor PhotomultiplierTube
70-I0282" High SpeedTV CameraSystemProcessesPhotoData
70-I0508" Log Amplifierfor BiologicalSignals
70-I0528 Techniquefor AnalyzingHumanRespiratoryProcess
72-I0614" SpectralAnalysisof MultipleTime Series
75-I0170 ContinuousDetectionof ViableMicroorganisms
• *Alsolistedin "lO most popular"Tech Briefs.
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Conclusion
If both individualshad selectedtitlesat randomwithoutreading
the Tech Briefsfor content,the probabilityfor selectionof a "most
popular"Tech Briefwouldhavebeen 92/503,or 0.183. The studyshowed
that both personswho participatedin the evaluationdisplayedaboutthe
sameprobability(0.172and 0.200)for selectingone of the "mostpopular"
Tech Briefs. But thesevalueswere not significantlydifferentfrom the
randomselectionvalue. Thus,it seemsthat,evena personfamiliar
with the NASATechnologyUtilizationprogramcannotselecta significant
percentageof Tech Briefsthathave provenpopularto the nationwide
scientificand technicalreadersof Tech Briefs.
The conclusionstatedaboveaffirmsthe operatingprocedureutilized
by the RTI BATeamfor the transferof technology.The team has always
advocatedthe advantagesof "pulling"technologyfrom the NASA source,in
contrastto the philosophyof "pushing"technologyfrom the NASA source.
The conceptof "pushing"technologyinvolvesthe selectionof an
itemof NASA technologyas beingusefulin a particularapplication,
and attemptingto promoteconsumerutilization.Notethat the selection
step,involvedin "pushing"technology,closelyresemblesthe attemptin
this studyto selecttechnologyitemswithwide publicacceptanceand
interest.
An economyof effortis obtainedwith the techniqueof "pulling"
technology,as practicedby the RTI BiomedicalApplicationsTeam. In
this process,the need is firstcarefullyidentifiedwithinthe biomedical
field. Then the fieldof NASAtechnologyis searchedfor the itemof
technologythat satisfiesthisneed. With thismethod,widespread
consumeracceptanceis seldoma problem. The methodalso seemsto have
more potentialfor identifyingsecondapplicationsof technology,in
whicha technologyitem is usedin a way distinctlydifferentfrom the
originalNASA use.
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I_ THEO PILKINGTON
'---] H.C. BEALL
"TOP TEN" SELECTION
(ITEMSONMOSTPOPULARLISTS)
1 2 3 4 5 6 7 8 9
TECH BRIEF CATEGORY
Figure 9. Summary of Tech Brief Study Results
73
74
8.0 CONCLUSIONS
During the reporting period, one commercial technology transfer
and six institutional technology transfers were completed. Twenty_ix
of 27 currently active transfer cases have the potential for introducing
new or improved commercial medical products incorporating NASAtechnology.
These numbers reflect the emphasis in the RTI Biomedical Applications
Team program on transferring technology by the introduction of com-
mercially available medical products. It is through this commerciali-
zation of NASAtechnological solutions that widespread utilization is
achieved. To better accomplish this goal, the team has studied in depth
the technology transfer process within the context of the medical field.
The insights gained from this study and from the team's experience
have resulted in the team's present methodology. By adapting its
methodology to the requirements for commercialization, the team is in-
creasing its effectiveness and efficiency in converting medical problems
and needs into commercial solutions based on aerospace technology. The
team concentrates on medical problems that are perceived as problems by
a significant fraction of the medical community and on obtaining the
participation of the medical manufacturing industry throughout the
technology transfer process. Frequent discussions by each team member
with industry representatives responsible for new product development
have led to a keen understanding of the potential difficulties in the
transfer of technology into the medical devices industrY. The team has
also stressed a more thorough survey of the potential user population to
determine the desired configuration and specifications for the medical
devices under consideration. '
Problem solving activities during the reporting period have involved
all NASAField Centers. This broad interaction between the team and NASA
scientists and engineers engaged in a broad spectrum of activities has
been an essential part of the identification of technologies relevant to
medical problems. By the combined use of NASAcomputer information
searches and direct contacts with field center staff, the team has been
able to identify the most appropriate aerospace technology for solving
specific medical problems.
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Team experiencehas demonstratedthat interaction with medical
mission agencies is importantto the BiomedicalApplicationsTeam program.
The expertiseand experience of the medical and engineeringstaffs of
these agencies in specificmedical areas can assist the team in vali-
dating the importanceof specificmedical needs. In addition, the
support by these agencies of the objectives in particulartransfer cases
can be of assistance in the commercializationprocess. The RTI team has
worked extensivelywith mission agencies by participatingin a number of
workshops and by consultingwith individualson specific transfer cases.
In addition, the RTI team has been an active participantin the establish-
ment of interagencyagreements between NASA and mission agencies.
Perhaps the most importantlesson that can be derived from the
team's experience in working with medical manufacturersis that technology
transfer in medicine is extremelycomplex. The barriers to technology
transfer are numerous and includethe characteristicsof medical device
manufacturers,medical marketingdistributionpractices,acceptance of
a new product by the medical community,and all the well-known barriers
to technology transfer in general and not peculiar to the medical field.
The team's better understandingof medical manufacturing,marketing, and
distributionhas enhanced its ability to form successfulcommercialization
strategies. However, there is still much to be learnedconcerning this
aspect of medical technology transferand the team will continue and
expand its interactionswith the medical industry in order to gain this
understanding. Of most importancein this area are ways of effectively
handling patents and licensingagreements. More generally,all aspects
of government-industryinterfacesmust be understoodand facilitated.
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APPENDIXA-I
SU_MARYOF BIOMEDICALAPPLICATIONSTEAMACTIVITIES
Activity Number
Commercial Technology Transfers 1
Institutional Technology Transfers 6
New Problems 17
IAC Information Searches 6
Medical Literature Information Searches 21
Problem Statements Circulated 7
Responses to Problem Statements 25
Projects Inactivated I0
Active Project Investigations 27
Field Centers Team Worked with in 1978 I0
Professional Papers Published
or Presented at Professional Meetings 8
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APPENDIXA-2
TECHNOLOGYTRANSFERS
CommercialTechnologyTransfers
DigitalTV DisplayDevice
InstitutionalTechnologyTransfers
EMG SpectralAnalysis
Enhancementof X-RayDiffractionImages
Lung SoundModeling
Multi-LevelCareManagement
OpticalProfilometer
SCA Receiverfor the Handicapped
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APPENDIXA-3
NEWPROBLEMS
ProblemTitle
BreastCancerScreeningTechniques
EMG SpectralAnalysis
Enhancementof X-RayDiffractionImages
GaitAnalysisDataBank
High SpeedDC-LogAmplifier
HydrocephalusShunt
InfraredTwo-DimensionalImaging
InvestmentCastingof ChromiumAlloys
Meterfor Very Slow FluidFlow
MicroliterFluidDeliverySystem
MicrowaveThermography
Multi-LevelCareManagement
NeuroelectricControl
PortableCoolingSystemfor Quadriplegics
PoweredRim ControlWheelchair
ProperTechnologyfor Cold FormingTitaniumAlloys
UV Dosimeter/SunburnMonitor
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APPENDIXA-4
INACTIVATEDPROJECTS
Problem Ti tl e
Advanced RuggedHearing Aid for Children
A Tool for Rapidly Fusing Surgical Suture Knots
Electromagnetic Flowmeter Calibrator
Inert Material for Insertion into Cranial Burr Hole
•Infrared Two-Dimensional Imaging
Sealing of Amputation StumpNeuromasto Prevent Pain
Upgrading of Performance of the Tracheal Stethoscope
UV Dosimeter/Sunburn Monitor
Vaginal Mucosal Blood Flow
V-Slotted HeadScrews
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, Problem Ti tl eii
Breast Cancer Screening Technique
" CompositeMaterialApplications
ControlledRate of Freezinga Liquid
FemaleIncontinence
GaitAnalysisData Bank
High SpeedDC-LogAmplifier
HorizontalShowerHydrocephalusShunt
ImprovedOpticsfor VitrectomySurgery •
.!
_i InvestmentCastingof ChromiumAlloys
Meterfor VerySlow FluidFlowi
MicroliterFluidDeliverySystem
o;I
i Microwave Thermography
_: Neonate Thermal Control Garment
_, Neuroelectric Control
_i NeuropathicTester
:: NewMethodfor CleaningTeeth{
PortableCoolingSystem for Quadriplegics
:I PoweredRim ControlWheelchair
,_ PressureTransducerCalibrator
I Proper Technology for Cold Forming Titanium Alloys
ProstheticUrinarySphincter
SimplePresettableTorqueBrakeSystem
TeletypeTestSet
TissueViability
TTY KeyboardTester
WeightAlleviationDevice
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BREAST CANCER SCREENINGTECHNIQUE
BATeam Personnel: Dr. Richard Scearce
ProblemStatement
A mass screeningtechnique that can reliably predictwhich women are
likely to develop breast cancer is needed.
- Breast cancer is the leadingcause of cancer deaths in American women.
At the present time, the only hope of modifyingthe picture is the detection
and removal of the lesion prior to its metastasis. This requires a cancer
detection techniquecapable of identifying: (1) most malignanciesin their
subclinicalstage (tumorsless than 5 mm in diameter},and (2) the fast grow-
ing cancers in their premalignantstage. Although much progress has been made
in developingdiagnostictechniques,none of the availablescreening techniques
fully meet the requirements.
DiagnosticTechniques
Mammography: Dr. Gerald A. Dodd (ref. I) recently reviewed the
status of the four clinical techniques used to detect breast cancer: (1)
X-ray mammography,(2) thermography,(3) physical examination,and (4) ultra-
sound. He found X-ray mammographyproduces the best results. In correctly
diagnosing breast cancer, it has an overall true-positiverate of 87%. This
includes the diagnosisof subclinicalcancers. Dr. John N. Wolfe (refs. 2, 3)
suggests mammographycan also be combinedwith other techniquesto predict
which women are likely to develop breast cancer. Based on the breasts' radio-
graphic appearance,Dr. Wolfe can classify women into four cancer-riskcate-
gories. His technique is promising, but the techniqueis still under evalua-
tion by the National Cancer Institute (NCI). If verified,the techniquewill
enhance X-ray mammography'spotentialas a screeningtool. However, X-ray
mammography has two major limitations: (1) its decreased effectivenessin
firm, young breast tissue, and (2) its use of low level ionizing radiation
which could be carcinogenic. Thus, physicians are not routinelyusing X-ray
mammographyto screen women under fifty-oneyears of age. Some better or
complementaryscreeningtechnique is needed.
Thermographyand Physical Examination: Neither thermographynor physical
examination,according to Dodd (ref. I), should be used as the sole modality
in a breast cancer screeningprogram, as both systems fail to reliably detect
subclinicalcancers. Their greatestuse is as an adjunct to X-ray mammography.
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Together, these three methodologiessignificantlyincreasethe accuracy of
screeningfor preclinicalcancer (ref. I), but this screeningsystem is ineffec-
tive against fast growing cancers.
Ultrasound: The spatial resolutionpresentlyobtainable in ultrasono-
grams is inadequatefor the detectionof subclinicalcancer (ref. I). However,
in the last five years research in water bath instrumentshas shown that
ultrasound has a role in the examinationof the breast, particularlyin screen-
ing the breasts of young women (ref. 4). Two new scannerswere recently made
commerciallyavailable,while several other breast scanning devices are under
development. All have improved spatial resolution,but it is questionableif
they are adequate to reliably detect subclinicalcancers. NCI has contracted
with the problem originatorto evaluate ultrasoundas a screeningtechnique
using two of the latest scanning devices.
ScreeningConcept
Screeningresults indicate ultrasoundand X-ray mammographyare
complementary (ref. 4), ultrasoundworking better in the young breast while
mammographyworks better in the older breast. If Dr. Wolfe's techniques
(refs. 2, 3) could be adapted to work with ultrasound,the physiciancould
identify the young women who are high risk for developing breast cancer,
without exposing these women to ionizing radiation. Unfortunately,skilled
and experiencedpersonnelare required to analyze the images Produced by
ultrasoundand mammography. This would make a mass screeningprogram very
expensive. If these images would be analyzed on a digital computer and simple
algorithms were used, it would be possible to develop a microprocessorsystem
to perform the analysis. Since the new ultrasound scanners and X-ray mammo-
graphy units digitallyprocess the image, the analysis system could be inte-
grated into the scanner. The scannerwould then automaticallyprovide the
mammogram and the risk category.
The constraintsand specificationsfor a breast cancer screeningtech-
nique are as follows:
(I) Algorithmsmust automaticallyanalyze the images and quantitate the
risk level.
(2) Processing algorithmsmust be digital and it must be possible to put
these algorithms in microprocessors.
(3) Scanning techniquemust not use ionizing radiation.
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INVESTMENTCASTINGOF CHROMIUM ALLOYS
BATeam Personnel: Dr. Clark Beall
Problem Statement
There is a move away from using gold in the constructionof dental fix-
tures, and chromium alloys seem to be attractive alternatives. These alloys
are fifty to seventy percent chromium,with the remainderbeing either nickel
or cobalt.
The metal dental fixture is actuallymade in a mold, part of which is
formed from the impressionmodel of the patient'smouth, and the remainder
being sculpturedby the dental technician. The mold is a ceramicwhich can
withstand the chromium based molten alloys. This process is referred to as
"investmentcasting." The problem that has been encounteredwith the chromium
alloys is that the molten metal and the ceramicmold material interact so as
to produce defectivesurfaces for the castings.
The dental researcherhas requesteda NASA technical informationsearch
and advice from NASA personnel for determiningthe ideal conditions,parame-
ters, and techniques for performingperfect investmentcastingof chromium
alloys.
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PROPER TECHNOLOGY FOR COLD FORMINGTITANIUM ALLOYS
BATeam Personnel: Dr. Clark Beall
Problem Statement
Titanium alloys have recently been introducedinto dentistry for the
manufactureof prostheses of the jaw. These prostheses replacemajor sections
of the upper and/or lower jaw that have been surgicallyremovedbecause of
cancer. Castings of the metal alloy are "cold formed" at room temperature,by
the surgeonwith various types of pliers, in order to achievea final fit to
the patient. A significantnumber of these prostheses have failed after
installationdue to chipping,cracking,or major fracture. A broken prostheses
must be replaced by yet another surgicaloperation.
The dental experts suspectthat the failure of these titaniumalloy
prostheses is due to fatigue susceptibility. They believe that the fatigue is
probably inducedas a result of the cold forming that is done during the
implant surgery. It may be that minute surface cracks are caused by the cold
forming of the alloy. Human body fluids perhaps invade the metal alloy via
these surface cracks, thus causing the cracks to propagate into large struc-
tural defects.
Two types of titanium metal alloys have been used for these prostheses:
"commercialpurity" titanium,and "aircraftalloy" (titanium-6-Aluminum-4-
Vanadium).
The dental researchershave asked for NASA technicaland metallurgical
advice in any of the followingareas:
(1) Comprehensivedetails about the process of fatigue susceptibilityof
the two above types of titanium alloy,
(2) The proper procedure for cold formingtitanium alloys,
(3) Possible surface treatments,such as etching procedures,that can be
used to eliminatethe microscopicsurface cracks that are caused by
cold forming of these titanium alloys.
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POWERED RIM CONTROL WHEEL CHAIR
BATeam Personnel: Dr. Richard Scearce
Problem Statement
Although many companiesmarket powered wheelchairs,the mechanism used
throughout the wheelchair industryto guide and control powered wheelchairs is
some form of a two axis joy stick. This mode of control is practical for many
wheelchair users, but some elderly persons and personswith muscular deficien-
cies lack the necessaryskill and time response to operate the wheelchair--
especially in confined quarters. They may be capable of operating nonpowered
wheelchairswith hand-rim control, but they quickly become fatigued and cannot
maintain their mobility. Since they are unable to master the joy stick control,
they cannot use availablepowered chairs. Thus, these individualsare isolated
to the confines of their homes. If they had a powered wheelchair that used a
control system similar to the hand rim control, they would regain much of
their lost mobility.
Applied Physics Laboratoryof Johns Hopkins University has proposed a
powered rim control techniquefor wheelchairs. They decoupledthe hand rim of
a conventionalmanually powered wheelchair from the wheel and used a transducer
to measure the hand rim's velocity. The transduceroutput controls the power
drive to each wheel. The concept is similar to power steering.
The Applied Physics Laboratory fabricatedand tested a demonstration
model. The results were very encouraging,but more engineeringdevelopment is
needed before a practicalwheelchair is available. The problem originator
believes NASA technologycan significantlyaid in this redesign effort. He
sees NASA technology as applicableto at least three of the wheelchair's
subsystems: high efficiencypower drive, integratedelectroniccontrol cir-
cuitry, and battery technology. A project for developingNASA's battery
technology is already planned, but the power drive and circuitryneeds are
unmet.
The power drive must be lightweightand reliable. It must be capable of
providing all the power needed to drive a wheelchair. In some designs, the
power drive should be able to share the total load requirementswith the
wheelchair user. (The maximum force a user can exert against the rim is 5
pounds).
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Circuit technology for 1/2 horsepowermotor pulse width modulated power
drives and optical tachometercircuits are needed. Monolithic hybrid solid-
state is preferred for a major portion of these systemsbecause they are
small, lightweight,reliable,and have low power consumption.
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NEUROELECTRIC CONTROL
BATeam Personnel: Dr. Richard Scearce
Problem Statement
The effective neuromuscularcontrol of the position of a human limb
resembleswhat is known to engineersas a closed-loopcontrol system. Various
sensory signalstravel toward the brain through major nerves to form the
"feedback"path. Motor signalstravel from the central nervous system through
adjacent nerve bundles and form the "forward"path. Ideally,a prosthesis
should utilizewhatever muscles and nerves remain at the injury site to form
an artificial control system that functionsmuch like the original closed-loop
system of the missing limb. In the case of virtuallyall of the presently
availablepowered prostheses,vision provides the primary feedback. The
prosthesis control system and the neuromuscularcontrol system can be united
to form the forwardcontrol path. The actual interfacebetweenthe two com-
ponents of the forward control path is a myoelectrode. This electrode is
mounted on the skin above a selectedmuscle. The electrodedetects the elec-
trical signal generatedby the contractingmuscle. A control system using
this arrangementis called a myoelectriccontrol system.
Myoelectriccontrol is not entirely satisfactory. This is particularly
true when the availablemyoelectricsignalsdo not originatefrom muscles that
were directly related to the human limb's motion that now is to be replicated
by the artificial limb. Myogenic control is also not satisfactorywhen the
control electrode is situated on a muscle that exerts nonporportionalcontrol
over the motion of a body limb. In such cases, the amputeemust concentrate
to supervisethe movement of the prosthesis. This "unnatural"control is one
of the limiting factors in patient acceptanceof powered prostheses. Varia-
tions in electrodeplacement and electrode interfacecharacteristicsmake the
control even more "unnatural."
In prosthetics,the term "degree-of-freedom"refers to a pair of antagon-
istic motions of a limb or prosthesis (for example, flexion and extension of
the elbow). The electrode interfaceand its impedancebecome major concerns
in the control of multiple degrees-of-freedomprostheses. Such prostheses
require several electrodepairs. The impedanceof each differentialpair must
be maintained reasonablystable with respect to each other. This stabilityis
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difficult to achieve when the patient perspires. These electrodepairs must
also be consistentlypositionedeach time the prosthesis is fitted to the
amputee. Currently,this positioningproblem is unresolved. Thus, it is
apparent that myoelectriccontrol has serious deficiencies.
The problem originator has proposed an alternateapproach consistingof a
neuroelectriccontrol system. Figure I is an artist's conceptionof the
system. He proposes to detect within the amputee's stump the electrical
signals being transmittedalong several pertinent nerves and to use these
signals to control an upper limb prosthesis. Special electrodesdetect the
neuroelectricsignal. The miniaturizedimplantedtelemetrydevice amplifies
the signal and transmits the signal to the prosethesis. The implantedsystem
is to be externallypowered via an RF inductancecoupling. Figure 2 is a
block diagramof the system. The design specificationsof the implanted
system are described in the followinglists:
A. Amplifier Differential
Input impedance >I0 M_ (resistancebetween each
input and ground)
Shorted input noise _ 5 mV
Voltage input range ± 5 NV to ± 800 NV p-p
Bandwidth flat response with 3 dB points at
IO0 Hz and 6 kHz
Gain to be chosen
Gain stability + 5% with power supply variations
caused by movement of induction
coils
Common Mode Rejection _ 80 dB
Ratio
TemperatureStability < 0.I NV/A 1¼C referred to input
voltage
B. Transmitter
FM modulated
Center Frequency Three differentvalues to be chosen so
that the three channels of information
can be transmittedsimultaneously
Modulation Sensitivity To be chosen
TransmittingDistance 2 meters (7 cm through body tissue)
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Figure 2. Block diagram of proposed neuroelectriccontrol system telemetry.
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C. Total Power Requirements
RF inducationcoupled
from outside the limb
Total quiescentpower As low as possible (preferably< mw)
drain
Outside voltage source 12 V
D. Materials
Electrodemetal 90% platinum-10%iridiumor 100%
platinum
Encapsulation Epoxy encapsulationenclosed in
dense alumina ceramic
The neuroelectriccontrolwould have several advantagesover myoelectric
control. First, the amputationoften badly damages, or re_moves,the muscles
of interestwhile the nerves are left intact. Second, the electrode interface
changes caused by perspiration(and tissue changes) would be eliminated.
Third, the overnight removal and replacementof the prosthesiswould not
change the electrodeposition. Fourth,the extraction of the control signal
directly from the nerve would provide the amputee a more "natural" control of
the prosthesis.
The concept of neuroelectriccontrol, however, introduces its own set of
problems. The first, and most obvious, is the developmentof an implantable
recordingelectrodethat may be attached to the nerve without inducing nerve
degeneration,while remainingcapableof detectingneuroelectricsignals. The
second problem is that the placement of the recordingelectrode requires
surgery. Third, a desirablemethod of transmittingthe neuroelectricsignals
outside the body would be by radio signal. This requires the developmentof
small, lightweight,durable electronicdevices that can be implantednear the
nerve.
The problem originator,in order to demonstratethe feasibilityof the
concept, solved the first problem. He and his colleagues developeda success-
ful recordingelectrodeand implantedit in rabbits. The electrodesuccess-
fully detected the motor control signals throughoutlong periods of implanta-
tion. Autopsy indicatedthat the nerves toleratedthe electrode. Currently,
he has several rabbitswith functioningimplantedelectrodes,and he is initi-
ating a program to test the electrodesin baboons.
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The other two problems remain. Surgery, however, is acceptable if the
neuroelectricsystem significantlyimproves the amputee's control of powered
prostheses. Surgery requires that the device be small and relativelyeasy to
implant. Thus, a miniaturized,durable electronicdevice is the major need
which must be satisfied. Although the problem originator has proposed a
conceptual system, hedoes not have access to the capabilityto solve this
problem. If a group, within NASA, with the needed capability could be identi-
fied, engineerson the problem originator'sstaff could assist in the develop-
ment and implantationof the device. The problem originator has asked if NASA
has technologyor experience in the developmentof reliable miniaturized
electronicsthat could be applied to this problem.
Reference
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PORTABLE COOLING SYSTEM FOR QUADRIPLEGICS
BATeam Personnel: Ms. Doris Rouse
Problem Statement
A portable cooling garment is needed for quadriplegics. These individuals
are unable to tolerate heat stress as a consequenceof their inabilityto
perspire below the level of injury. This garment, therefore,would open new
employment and daily living opportunitiesfor individualspreviously confined
to a temperaturecontrolledenvironment.
One dangerous sequela of the quadriplegiacaused by cervical spinal
lesions is a vulnerabilityto thermal stress. This condition is due to the
interruptionof automaticpathways mediatingthermoregulatorysweating and
vasomotionas well as interruptionof motor pathways controllingshivering.
In a recent study, six quadriplegicmen were exposedto a 38°C environmentfor
two hours while several physiologicalparameterswere monitored (ref. 5). The
results, as shown in Figure 1, illustratethe danger of heat stress in individ-
uals with impaired sweating response. During heat exposure, the quadriplegics
developed hyperthermiaand hyperventilation,as well as significantlyincreased
oxygen consumptionand heart rate. The potential for heat stroke on continued
exposure is obvious.
In addition to spinal cord injuries,severalother pathologicalconditions
result in impaired sweating and, therefore,vulnerabilityto heat stress.
Ectodermal dysplasia is a congenitaldisorder with decreasedsweating as a
result of a reduced number of sweat glands. The effect of a heat stress on an
ectodermal dysplasic is shown in Figure 2. The drastic increases in heart
rate, oxygen consumption,and pulmonaryvolume resemblethose seen with the
quadriplegics.
In another disease, multiple sclerosis,the demyelinationoften causes
lesions in the autonomic system that lead to impairedthermoregulation.
The constraintsand specificationsare as follows:
(1) Cooling garment should be as lightweightand unobtrusiveas possible.
Ideally, a coolingvest to be worn under everyday clothes would be
sufficient. A cooling cap should be avoided if possible.
(2) Cooling unit should weigh no more than 12 pounds and should be
easily mounted on a wheelchair.
(3) Garment should be easy to put on and remove. If Velcro fastenersor
zippers are used, large loops should be put on the outside for easy
removal by individualsunable to grip a smallertab.
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(4) Cooling unit should be battery powered and rechargeable.
(5) Cooling unit should have capability of cooling for four to eight
hours, dependingon the environmentalconditions.
(6) A user regulatedtemperaturecontrol on the cooling unit would be
convenient. Feedback from the patient's skin to the control unit is
not required.
The RTI Bateam is investigatingthe use of NASA's liquid perfused garment
technology as a solution. "
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HYDROCEPHALUSSHUNT
BATeam Personnel: Dr. Richard Scearce
Problem Statement
Hydrocephalusis a conditionof abnormal enlargementof the cerebral
ventricles caused by a rise in pressure of the cerebrospinalfluid. Although
the conditionmay arise as a result of tumors, infection,or trauma, it is
normally a congenitalconditionassociatedwith malformationsat the base of
the brain. The occurrenceof hydrocephalusis surprisinglycommon (4-12 per
1000 births). Medical treatment has been of little use, and surgicaltreatment
has increasedthe one-year infant survival rate to only 15 to 20 percent.
Current hydrocephalusshunts fail frequentlydue to inlet blockage of the
ventricularcatheter. The single tube catheter is blocked by either an in-
growth of choroid plexus or hemorrhage cellular and fibrin debris. During
the first severalyears after birth, hydrocephalicchildren typically require
two revisions(surgicalreplacementor correctionoperations)per year to
maintain proper functioningof the shunt.
Many design modificationsof the ventricularcatheter of the hydrocephalus
shunt have been used, unfortunatelyresulting in little or no improvementin
long-term success rate. A design modificationof the ventricularshunt's
inlet is needed. This modificationshould minimize tissue ingrowth and debris
blockage of the inlet.
The team is investigatingLewis Research Center's suggestionto develop
an inlet using ion etching techniques.
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MICROWAVETHERMOGRAPHY
BATeamPersonnel: Dr. Clark Bea11
Problem Statement
This evaluation of passive microwave thermography originated from a
request of the NASAGoddard Space Flight Center's Office of Technology Utili-
zation. Many personnel of this NASAcenter have expertise in microwave tech-
nology, and it was felt that this technology could be successfully applied to
many specific areas of medical practice.
The overall objective of this study is to evaluate microwave thermography
in laboratory animals under normal and abnormal conditions in order to test
its use for the measurement of tissue temperaturesat the surface of the body
and in deep tissues. The long-term goal would be to discover possible medical
applications for this technique in clinical medicine. The principal emphasis
of this study will be directed at the subcutaneous structures of the body,
such as brain, spinal cord, peripheral nerve, muscle, bone, and blood vessel.
The potential importance of the ability to measure temperature gradients
deep within the body tissue may be unlimited in clinical medicine and research.
The proposed research will initially be concentrated on the potential neuro-
logical uses. The possible clinical applications are as follows:
(1) Detection of core temperatures in the brain and spinal cord follow-
ing various types of trauma to localize hemotomasor brain edema,
(2) The identification of brain abscesses deepwithin the substance of
the brain,
(3) The identification of spontaneous blood clots in the brain, and
(4) The use of temperature gradients in the evaluation of certain diseas-
es which result in temperature changes in the body, such as autonomic
and vascular dysfunction.
The facilities of Duke University Medical School are available for this
study. Specifically, the Division of Neurological Surgery is equipped to
carry out detailed neurophysiologic, neurovascular studies using up-to-date
monitoring and electronic equipment. For the purposes of long-term animal
studies, the university maintains a vivarium under the guidelines of the
National Institutes of Health.
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INFRARED TWO-DIMENSIONALIMAGING
BATeam Personnel: Dr. Clark Beall
Problem Statement
A professorof physiology at Duke UniversityMedical Center, Franz Jobsis,
Ph.D., has proposed a scheme for noninvasivelyassessing the oxygenationof
human tissue. Medical specialitiesranging from surgery to clinical diagnosis
routinely require some type of informationabout tissue oxygenation. Several
fields of medicine, therefore,would benefit from the developmentof such a
technique. In particular,the brain is perhaps the most difficultorgan in
which to measure oxygen delivery to the tissue. Presentmedical techniques
are invasive;a burr hole is drilled throughthe skull for the insertionof
the appropriatesensors. The promise of a noninvasivetechnique for the
measurementof actual brain tissue oxygenationis, therefore,welcome news
indeed.
The proposed noninvasivetechniquerelies on a physiologicalphenomenon
that occurs in virtuallyall soft tissues of the body. The observed phenom-
enon is the in vivo reversible light absorptionchanges in a selected species
of cytochromewhen the cytochrome changes from its oxygenated state to its
reduced state. When the cytochrome exists in its oxidized state, a weak
light-absorptionpeak can be observed in the 780 to 870 nanometerregion of
the near infrared (IR) of the spectrum. This absorptionpeak disappearswhen
the enzyme is reduced. The proposed monitoringtechnique relies upon the
spectral change of this cytochrome. Dr. Jobsis has publisheda paper (ref. 1)
describing the system that he now uses. Essentially,it is a one-dimensional
system whereby a light pipe directs monochromaticinfrared light onto one
side of the skull while a light pipe on the opposing side of the skull conducts
the emerging IR light to a detector. The results from these studies look so
encouragingthat Dr. Jobsis wants to expand the techniqueinto a two-dimensional
viewing system.
If the IR light emerging from the skull could be recorded as a two-
dimensionalimage, one would essentiallyhave a "picture"of the skull con-
tents. The picture's various levels of shadowwould correspond to areas of
variation in the oxygenationof the cytochrome. Areas of dead cells would
appear in contrast to surroundingareas of living cells. Blood vessel clots
would be expected to appear in suitable contrastto surroundingareas of
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living cells. Additional effects could be observed by having the test subject
hold his breath or hyperventilate in order to change the oxygen content of the
blood.
Dr. Jobsis has requested the team's assistance in obtaining an imaging
system for IR in the wavelength region of 700 to 1,000 nanometers. The detec-
tion system must be very sensitive to the IR light because the light emerging
from the tissue is of very low intensity. The IR light that serves as the
test beam is generated from solid state IR lasers that are multiplexed into a
mixed fiber optical bundle. The multiplexpattern of pulsed IR light will be
used to advantage in recoveringthe absorption information.
There are at least four NASA field centers that have state-of-the-art
technology in IR detectionand imaging. Interviewswill be conducted at all
four centers to determinethe most appropriatetechnology for this application.
Reference
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HIGH SPEED DC LOG AMPLIFIER
BATeam Personnel: Dr. Clark Beall
Problem Statement
The wide variety of transducersused in medical research produce analog
signalswhich can vary in amplitudeover several orders of magnitude. Often,
it is desirable to observe or record the time course of such an analog
signal on a single plot or record. In order to accomplishthis without range-
switchingof the instrumentation,one can utilize logarithmicprocessing.
Logarithmicprocessing is a unique data compressiontechniquewhich greatly
amplifies the smaller amplitudesignalswhile, at the same time, attenuates
the larger signals. At the present time, there are availablecommercially
several types of electronicfunction modules that convert alternatingcurrent
(a.c.) analog signalsto voltage levels proportionalto the logarithmof the
input voltage level. These devices are often used to process radar return
signalswhich are a.c. signals that can vary over several orders of magnitude
in voltage amplitude. In the biomedicalsciences,however, the logarithmic
conversionof direct current (d.c.) signals is more important.
The logarithmicconversionof d.c. signals is a more difficultproblem
because the frequencyresponse of the logarithmicconverter falls off as a
functionof the d.c. signal amplitude. Some types of logarithmicd.c. conver-
sion modules are commerciallyavailable. Unfortunately,the performanceof
all of these modules is unsatisfactorywhen they are used to measure extremely
low current (10-6 to 10-11 ampere) at high frequency (50 kHz to 1MHz). This
type of analog signal is typical of the analog output signal of various types
of transducersfound in applicationssuch as ion detectors,current relaxation
experiments,and recordings of biologicalmembrane current.
There is a need for an electroniccircuit that can respond to d.c. analog
signals in the frequency range from lOHz to IMHz and in the current range of
- 10-11 to 10-6 ampere. Logarithmicconvertersare utilized outside the biomed-
ical field in many areas of the chemicaland physical sciences, in research
and in industry. Therefore, it is anticpatedthat a new type of logarithmic
converter,capable of the above specifiedperformance,would find a wide
acceptance in the marketplace.
References
1. "Designersguide to: logarithmicamplifiers,"EDN 18:42-51 (5AUG73).
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and Meth. 116(1):74-5 (1974).
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UV DOSIMETER/SUNBURNMONITOR
BATeam Personnel: Dr. Clark Beall
Problem Statement
Outdoorwork and recreationalactivitiescause many people to be exposed
to extended periods of solar radiation. For those with normal skin, the
adverse effects of solar radiationare caused by the ultraviolet(UV) portion
of the solar spectrum. For convenience,the UV can be subdividedinto three
bands: UVA (320 to 400 nanometers),UVB (290 to 320 nanometers),and UVC
(less than 290 nanometers). Fortunately,the ozone layer of the stratosphere
absorbs virtuallyall of the UVC band. This particular band of radiationcan
cause skin cancer. Sunburn is due to the radiationof the UVB band. A much
greater dosage of UVA is needed to produce reddeningof the skin or actual
sunburn.
• Although many seek solar exposure to develop a "healthy tan," UV initiates
the tanning, and the suntan is actuallythe manifestationof the body's mechan-
ism of shielding itself from furtherUV injury. Unfortunately,the repeated
exposure regimen that is necessaryfor the stimulationof a suntan also brings
with it an increasedrisk of skin cancer.
Commercial suntanningoils and creams are properly referredto as sun-
screens in medical literaturebecause these aids actually filter out the UVB
radiationand thereby prevent the suntanningradiationfrom being absorbed by
the skin. Thus, they are actually effective in preventing initialoverexpo-
sure due to extended periods of time in the sun.
Sunburning is caused by a combinationof three factors: solar intensity,
period of exposure, and conditionof the skin's tan at the beginningof expo-
sure. The first factor is particular]ydifficultto assess, due to such
variables as changing cloud cover, haze, and time of day. The second factor
can result from a lack of attention to the passage of time during recreational
or work activities. A device that can sum over time or integratethe amount
of UVB radiationto which an individualis exposed is needed. When a predeter-
mined dosage has been received,the device should sound an alarm.
References
1. Blum, H. F., "Ultravioletradiationand skin cancer: in mice and men,"
Photochemistryand Photobioloqy24:249-54(1976).
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ENHANCEMENTOF X-RAY DIFFRACTIONIMAGES
BATeam Personnel: Dr. Clark Beall
Problem Statement
X-ray diffractionis a valuable medical researchtechnique for the analy-
sis of the size, orientation,and packing of an array of biomolecules. Although
electronicdetectors are now being used by a few researchers,most X-ray
diffractionpatterns are still being recorded on photographicfilm plates. An
acceptable film plate record of a diffractionpattern consists of a very faint
image of concentric arcs and circles that are typicallyspaced only fractions
of a millimeterapart. The exact spacings can be read visually through a
jeweler's loupe, or the film can be read by an optical densitometer.
Experimentalconsiderationsimpose upper limits both on the X-ray inten-
sity that canbe used and the time duration that an X-ray tube can be run
continuouslywithout deterioration. A means of producing acceptableX-ray
diffractionimageswith a minimum of X-ray intensityand time of exposure is
needed.
BarbaraAskins of the NASA Marshall Space Flight Center has published
several scientificpapers describing research conductedat the center for the
enhancementof photographicimages on films. NASA Tech Brief MFS-23461out-
lines the method. This technology is being tested for its applicabilityto
the enhancementof the photographicimages of the X-ray diffractionpatterns.
The problemoriginator has begun acquisitionof the laboratoryequipment
that is needed for the process.
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METER FOR VERY SLOW FLUID FLOW
BATeam Personnel: Dr. Clark Beall
Problem Statement
The flow of fluid becomes rather difficultto measure when the flow rate
drops below 0.5 ml/min. However, heparin and other drugs are often dispensed
at even lower flow rates. Thus, a need exists for meter systems capable of
precision measurementof fluid flow at rates below 0.5 ml/min. The meter
should generate an electronic signal that can be used as a feedback signal for
the control of fluid pumps and valves. Also, the electronic signal could be
routed to a plotter, or other display device, for recordingthe time course of
the rate of drug delivery.
NASA Tech Brief MSC-18112describes an electronicmeter for the precision
measurementof very slow flow rates. The system can detect flow rates up to
0.5 ml/min with a sensitivityof 0.01 ml/min. The technicalsupport package
for this Tech Brief describes the constructionof the flow sensor and includes
the schematicof the electroniccircuit.
One problem with this device is that the sensor must be inserted in
series with the fluid delivery line. Thus, the sensor must be sterile. This
need not be a complicatingfactor if the sensor can be manufacturedas an
expendable item for one-time use. However, if the sensor is so expensive that
it must be reused, it must be able to withstandthe rigors of sterilization.
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MULTILEVEL CARE MANAGEMENT
BATeam Personnel: Dr. Richard Scearce
Problem Statement
The Veterans Administration(VA) developedthe Multilevel Care Program
to reduce the cost of operatingtheir 200-hospitalhealth care complex. In
this fiscal and facilitiesmanagementprogram, they divide the health care
into five levels--fromintensivecare to outpatientcare. They also divide
the hospital facilitiesusage management and the cost accounting into five
levels. This division cuts across establishedhospital organizationlines
(e.g., Dept. of Surgery, Dept. of Medicine, etc.), thus creating a matrix
managementproblem that complicatesthe program implementation.
The distinctivecharacteristicsof a VA hospital further complicate
program implementation. Each VA hospital is autonomous. Although many simi-
larities exists, each hospital is significantlydifferent. Size, staff capa-
bility, and medical emphasis all vary. Implementationof the multilevel care
program must consider these differences. The program must assimilate these
differentorganizationalstructuresand be able to reduce operating costs
without reducing health care delivery.
The problem originatorrequestedNASA technology specificallyrelated to
program management and to program and policy analysis. He wishes to utilize
these technologiesto aid in the organizationand managementof the multi-
level care program implementation.
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GAIT ANALYSIS DATA BANK
BATeam Personnel: Dr. Richard Scearce
Problem Statement
Advances in technology have resulted in the improvement of gait analysis
as an analytical tool for rehabilitation. For example, new techniques of
electromyography can be used to simultaneously monitor the contraction patterns
of 16 muscles. Also, force plates are now available which can sense the
dynamic pressure distribution on the bottom of the human foot. This enables
the medical researcher to determine when, and in what manner, the foot of the
subject contacts and leaves the ground during a test session. New optical
tracking techniques can sense the path through space that is taken by prese-
lected points on the surface of the body of the human subject during test
sessions. Computers are available which can rapidly analyze the data that is
generated by the various electronic sensor systems. Finally, graphic displays
can present the integrated data from the computer to the rehabilitation
researcher in a manner that allows detailed study and analysis of the subject's
gait. Once the defects of the subject's gait have been documented, the causes
of these defects can be identified and corrected through therapy.
Even though this wide selection of instrumentation is presently available,
it is seldom used by physicians and therapists because there are much more
data available to the researcher than he can handle. The rehabilitation
researchers have yet to devise means to extract from the voluminous data the
pertinent parameters that correlate well with specific diagnoses.
The problem originator has one of the most advanced gait analysis labora-
tories in the world which he uses as a clinical tool. Records from each gait
analysis performed in this laboratory are compiled into an ever expanding gait
analysis data bank. Currently, this data bank contains the gait records of
415 patients, with each record containing the following types of information:
Electromyographic Data
8 channels of data, 3 seconds of data per channel, digitized at the
rate of I sample each 2 milliseconds;
Spatial Location of Body Points
24 body points, 3 seconds of x, y, z 3-dimensional spatia! data per
selected body point, with all data digitized at the rate of I sample
per 20 milliseconds;
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Force-Plate Data
16 channels of data that have been reduced to 3 types of information
(vertical force, fore and aft force, and mediolateral force), accum-
ulated as 3 sections of data on these 3 types, sampled once every 2
milliseconds.
" From this growing volume of data, the problem originatormust identify
parameters that correlatewith disease states, hereditarydefects, and then
plan treatments. He has asked whether NASA has technology,in the form of
data processing,analysis,and storage techniques,that is applicable to his
research.
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MICROLITER FLUID DELIVERY SYSTEM
BATeam Personnel: Dr. Clark Beall
Problem Statement
A need has been defined for a fluid delivery system capable of delivery,
upon demand, of microliter quantitiesof sterile fluid into an open air fluid
reservoir. The accuracy of fluid delivery must be ± 2 percent. The range of
fluid delivery lies within the range of 10 microlitersto 150 microliters. It
is desirablethat the measured volume of fluid be deliveredin less than 15
seconds. It is also desirableto control the delivery system by electronic
command signals. This would permit programmingthe system to operate in
synchronywith other units, allowing delivery of several fluids into a chemi-
cal reaction chamber in a predeterminedsequence.
NASA Tech Brief B72-10708describeda concept for an infusionpump that
utilized gas to drive from a separate reservoirat very low delivery rates.
However, no control system was outlined either for constant flow or for dis-
crete volume delivery.
MSC-14905 is a Tech Brief that describes a gas-drivensystem for delivery
of fluid at a constant rate from a bladder reservoir. However, there is no
provision for controllingthe delivery of discrete quantitiesof fluid upon
demand.
An ideal solutionwould seem to be one that utilizes electrochemistryto
generate a known quantity of gas which would, in turn, force a known quantity
of fluid from a small fluid reservoir. Such a solutionwas touched upon by an
engineer at Lewis Research Center in his response to a previous RTI problem
statement (CM-1) dealingwith a bedsideconstant rate infusionpump. Perhaps
such a concept could be consideredfor the solution to the need for delivery
of discrete volumes of fluid in the microliter range.
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EMGSPECTRALANALYSIS
BATeamPersonnel: Dr. Richard Scearce
Problem Statement
The rapid expansion of marine resource development has stimulated man's
interest in deep-sea diving. This interest is evident in the rush to exploit
- offshore oil deposits. A well cannot produce unless a diver has attached the
pumps and valving on the ocean floor. Thus, offshore drilling requires scuba
divers to dive and work at depths of 700 to 1,000 feet of water. However, man
develops tremors at depths of 1,000 feet and experiencesmomentary lapses into
deep sleep at 1,500 feet. Either phenomenoncould cause an accident,which at
those depths would be fatal. These phenomenaare not understood.
Dr. Ackerman is studying the physiologicaleffectsof deep-sea diving.
In his research, he instrumentsanimals and places them into pressure chambers
simulating deep-sea dives.
One measurementof particular interest is the electromyogram(EMG). Dr.
Ackerman plans to do a spectral analysis of the EMC data to detect the subtle
changes in frequencycontent that are the first signs of the onset of tremor.
The researcher asked the team whether NASA had developedcomputer software for
this purpose that he could use in his diving studies.
B-33

-" " I
APPENDIXC
CONFERENCESAITENDED,PRESENTATIONS,AND
PUBLICATIONSBY BATEAM EMBERS
L_
CONFERENCES
I. The Conferenceon the BiomedicalApplicationsof EngineeringSkills
to the Problemsof the Elderly,was held January26, 1978,at the
JewishInstitutefor GeriaticCare in Long Island,N.Y. Dr. R. W.
Scearceand Ms. D. J. Rouseattendedthe conference,whichwas
sponsoredby the NationalAeronauticsand SpaceAdministrationand
the NationalInstituteon Aging.
2. The 22ndAnnualBiophysicalSocietyMeetingheld on March26-29,
1978,in Washington,D.C.,was attendedby Dr. H. C. Beall.
- 3. Ms. DorisRouseand Dr. R. W. Scearceattendedthe 13thAnnualCon-
ferenceof the Associationfor the Advancementof MedicalInstru-
mentationheldon March28-Aprill, 1978,in Washington,D.C.
4. Dr. H. C. Beallattendedthe two-day"Workshopon Monitoringthe
the AcutelyBrain-InjuredPatient,"sponsoredby the National
Instituteof Neurological,CommunicativeDiseasesand Strokeof
NationalInstituteof Health,held in Winston-Salem,N.C. on 5-6
June 1978. The workshopwas hostedby the Departmentof Neurology,
BowmanGray Schoolof Medicineof Wake ForestUniversity.NASA
telemedicinetechnologywas describedby a film presentedby Mr.
NormanBelascoof the JohnsonSpaceFlightCenter.
5. One June7-9, 1978,Dr. JamesBrownand Dr. R. W. Scearcetook part
in the NationalAeronauticsand SpaceAdministrationand the Bureau
of the Educationof the Handicappedjointlysponsoredworkshop.
Representativesfromboth organizationsidentifiedopportunities
for applyingtechnologyto specialeducationneeds.
6. Dr. Brownand Ms. Rouseparticipatedin the July 25 and 26, 1978
BiomedicalRTOP reviewat the NASA Scientificand TechnicalIn-
formationFacilityin Baltimore,Maryland.
7. On AugustlO and II, 1978,Dr. R. W. Scearceattendedthe Inter-
nationalDisabledExpo in Chicago,Illinois.The ParalyzedVeterans
of Americasponsorthisannualmeetingto providea forumfor
interactionbetweenmanufacturers,professionals,and the disabled.
8. Ms. Rouseparticipatedin a programreviewfor the FEMUICA/FEMURA
projectat JohnsonSpaceCenteron August15 and 16, 1978.
9. Ms. Rouseand Dr. Scearceattendedthe InteragencyConferenceon
RehabilitationEngineeringin Washingtonon September4-8, 1978.
" lO. On October16, 1978,in Washington,D.C. Dr. JamesBrownand Dr.
RichardScearcemet with representativesfrom lO governmentagencies.
This was the secondin a seriesof meetingsin whichthe development
of a rehabilitationfacilityis beingconsidered.Participants
unanimouslyagreedthatNASA shouldmanagethe project,and the
feasibilitystudyshouldbe initiatedimmediately.
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CONFERENCES (continued)
If. On October27, 1978,Dr. Scearceattendeda seminarat the Applied
PhysicsLaboratoryin Baltimoreon thedevelopmentof an implantable
infusionpump. Dr. WilliamSpencerof SandiaLaboratorieswas the
main speaker.
12. In responseto a requestby Mr. Ray Whitten,Dr. RichardScearce
participatedin a workshopheldNovember20, 1978,at the University
of FloridaMedicalSchool. Representativesfromthe fieldsof
rehabilitation,prosthetics,orthopedics,neurosurgery,and en-
gineeringdiscussedthe hip disarticulationprosthesisand how it
mightbe improved.
13. On December II, 1978, Dr. Beall attended a colloquiumon "Non-
DestructiveTesting" at Langley Research Center.
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PRESENTATIONS
I. On March 14, 1978,Dr. R. W. Scearcegave a presentationon the
BiomedicalApplicationsTeam programto a classon Technology
Assessmentat the Duke UniversityDepartmentof MechanicalEn-
gineeringand MaterialScience,in Durham,NorthCarolina.
2. Dr. JamesBrownpresenteda paperentitled"MedicalTechnology
Transfer"at LangleyResearchCenteron May 3, 1978.
3. On June 8, Dr. Brownpresenteda paperentitled"NASA'sBiomedical
ApplicationsTeam Program"at a workshopheld in Baltimoreon
innovativeapproachesto the designof teachingfacilitiesfor
severelyretardedstudents. The conferencewas jointlysponsored
by NASA,the NationalAssociationfor RetardedCitizens,and the
Bureauof Educationfor the Handicapped.
4. Ms. Rousepresenteda paperentitled"MechanicalMethodsof In-
continenceManagement"at the InteragencyConferenceon Rehabili-
tationEngineeringin Washington,D.C.,on September7, 1978.
C-5
PUBLICATIONS
I
I. J.N. Brown, W. A. Fisher, and F. T. Wooten, "Medical Technology
Transfer," Proceedings of the Fifteenth Space Congress, Cocoa Beach,
Florida, April 26L28, 19781
2. B.S. Wilson and S. M. Scott, "Hemodynamic Design Considerations for
an Improved Artery Shunt Prosthesis," in Bio-Fluid Mechanics,
D. J. Schenck (Ed.), VPI Press, Blacksburg, Va., 1978, pp. 93-98.
3. F.T. Wooten, W. W. Waring, M. J. Wegmann, W. F. Anderson, and
J. D. Conley, "Methods for Respiratory Sound Analysis," Medical
Instrumentation 12(4) (1978) pp. 254-257.
4. James N. Brown, Leader of the Health Technology Working Group, "Health
Technology", Aerospace Technology Transfer to the Public Sector, An
AIAA Workshop Conference, Crystal City, VirgTnIT,_er 9-11, 1977,
Sponsored by NASA, edited by Jerry Grey and Martin Newman, June 15,
1978, pp. 35-44.
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